Functional Comparison of Conventional AFOs with the Dynamic Response AFO by Ruble, Mitchell
Marquette University
e-Publications@Marquette
Master's Theses (2009 -) Dissertations, Theses, and Professional Projects
Functional Comparison of Conventional AFOs
with the Dynamic Response AFO
Mitchell Ruble
Marquette University
Recommended Citation
Ruble, Mitchell, "Functional Comparison of Conventional AFOs with the Dynamic Response AFO" (2016). Master's Theses (2009 -).
Paper 373.
http://epublications.marquette.edu/theses_open/373
FUNCTIONAL COMPARISON OF CONVENTIONAL AFOs  
WITH THE DYNAMIC RESPONSE AFO 
 
 
 
By: 
Mitchell Ruble, B.S. 
 
 
 
 
 
A Thesis submitted to the 
Faculty of the Graduate School, Marquette University, in Partial Fulfillment of the 
Requirements for the Degree of Master of Science 
 
 
 
 
 
 
Milwaukee, Wisconsin 
August, 2016  
ABSTRACT 
FUNCTIONAL COMPARISON OF CONVENTIONAL AFOs  
WITH THE DYNAMIC RESPONSE AFO 
 
 
Mitchell Ruble, B.S. 
Marquette University, 2016 
 
 
   
 Ankle foot orthoses (AFOs) are commonly prescribed to provide stability and foot 
clearance for patients with weakened or injured musculature. The Dynamic Response AFO 
(DRAFO) was designed to improve proprioception at heel strike.  The design includes a rigid 
outer shell with a cut out heel and a soft inner lining; it is typically aligned in plantarflexion and 
may incorporate external heel wedges. The objective of this study was to investigate the effects 
of the DRAFO design features and contrast its biomechanical function with that of conventional 
locked and articulating AFOs. The research hypotheses were: 1) DRAFO-assisted gait 
parameters (e.g. ankle plantarflexion during early stance, cross-over times of the shank and thigh 
vertical angles during stance, step width, dorsi activity duration during stance, and center of 
pressure progression during loading response) will approximate the no AFO condition and 2) 
DRAFO-assisted gait parameters (e.g. ankle and knee kinematics, cross-over times of the shank 
and thigh vertical angles during stance, peak foot progression angle, step width, stance phase 
dorsiflexion activity duration, and mediolateral motion of the center of pressure) will differ from 
the locked and articulating AFOs. 
 
 Ten young healthy subjects were recruited for gait analyses during level treadmill 
walking; four AFO conditions were contrasted. After five minutes of AFO and treadmill 
acclimation, each subject walked for two minutes at the self-selected walking speed on a level 
treadmill. Acquired data included lower extremity joint and segment kinematics, dorsiflexion 
and plantarflexion muscle activity, and treadmill kinetic data. 
 
 Ambulation in the DRAFO demonstrated significantly greater knee flexion and ankle 
plantarflexion than with conventional AFOs, the foot progression angle was reduced in the 
DRAFO relative to the no AFO condition, the center of pressure progression for the DRAFO was 
more medial than that observed during the no and articulating AFO conditions, and the time to 
transition from an inclined to a reclined shank during swing was delayed. These findings suggest 
that the plantarflexed alignment, external heel wedges, and perhaps the soft heel features of the 
DRAFO design affect lower limb joint and segment kinematics, while the rigid structure 
provides stability to the ankle and subtalar joints.
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Chapter 1: Introduction and Motivation 
 Ankle foot orthoses (AFOs) are assistive rehabilitative devices used to treat pathologic 
gait due to stroke, brain diseases such as cerebral palsy (CP), and muscular diseases such as 
muscular dystrophy [1]. AFOs may be prescribed to provide: rest, immobilization, protection, 
control, assistance/resistance of movement, and/or anatomical correction of the ankle and 
subtalar joints [1, 2]. One common problem addressed by AFOs is drop foot, caused by weak 
dorsiflexors, which may adversely affect foot clearance during swing phase [3-6]. Common 
compensatory mechanisms include pelvic hike, circumduction, and vaulting [7], the use of which 
can lead to additional pathologies and potentially increased energy expenditure. AFOs stabilize 
the foot in a neutral or flexed position thereby assisting toe clearance during swing phase and 
minimizing the need for compensatory mechanisms. 
 Specific AFO prescription is conducted on an individual basis, taking into consideration 
the functional needs and physical limitations of the patient. For example, weakness of the 
gastrocnemius-soleus muscle group may require more proximal AFO trimlines and increased 
rigidity to control tibial motion and potential knee instability during stance; weakness of the 
pretibial muscles often require dorsiflexion assists or neutral ankle positioning to facilitate toe 
clearance during swing [2]. AFO prescription and design variations include the level of control 
of the ankle, foot plate length, orthotic stiffness or rigidity of the foot plate/ankle joints/uprights, 
proximal trimline, fabrication material, rigid/free/assisted ankle joints, orthotic alignment, and 
inclusion of supplemental inserts [1, 2]. 
 Although several studies investigated the effects of AFO design parameters on functional 
outcomes and gait, no study has as yet investigated the Dynamic Response AFO (DRAFO), an 
alternative AFO design with a flexible heel to enhance proprioception during stance. In addition 
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to its unique semi-rigid design, the alignment of the DRAFO also varies from that of traditional 
AFO designs.  
The purpose of this study was to use motion analysis to contrast three different AFO 
designs during treadmill walking for able-bodied subjects. Specifically, this study compared the 
DRAFO to both a locked and an articulated plastic AFO. The resultant lower extremity gait 
kinematics, ground reaction force kinetics, and EMG were contrasted for these three AFO 
designs, as well as for the no AFO condition. The specific aims of this study were to investigate 
the effect of AFO design on: 1) lower limb kinematics during stance and swing, 2) kinetics 
during stance, and 3) dorsiflexion and plantar flexion muscle activity during both stance and 
swing during treadmill walking.  The specific research hypotheses (see Table 1.1) investigated in 
this study were  
1) DRAFO-assisted gait parameters (e.g. early plantarflexed ankle angle, swing phase shank 
and thigh segment angle cross-over times, step width, early stance phase dorsiflexion 
activity, and center of pressure progression during loading response) will approximate 
that of the no AFO condition  
2) DRAFO-assisted gait parameters (e.g. ankle and knee kinematics, stance phase shank and 
thigh segment angle, step width, stance phase dorsiflexion activity, and center of pressure 
progression during loading response) will differ from that for articulating and rigid 
AFOs.  
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Table 1.1 Research hypotheses regarding the DRAFO and no AFO and DRAFO versus 
conventional AFO conditions for various gait parameters. 
Research Measure Hypothesis 1 
DRAFO ≈ no AFO 
Hypothesis 2 
DRAFO ≠ conventional AFOs 
Soft heel of DRAFO 
     Ankle kinematics (loading 
response) 
     Ankle kinematics (stance) 
     Center of pressure progression 
(loading response) 
     Step width 
     Dorsiflexion activity (stance) 
 
≈ 
 
 
≈ 
 
≈ 
≈ 
 
≠ 
 
≠ 
≠ 
 
≠ 
≠ 
External heel wedges 
     Shank segment cross over time 
(stance) 
     Thigh segment cross over time 
(stance) 
     Shank segment cross over time 
(swing) 
     Thigh segment cross over time 
(swing) 
 
 
 
 
 
≈ 
 
≈ 
 
≠ 
 
≠ 
Plantarflexed alignment 
     Knee kinematics (stance and 
swing) 
     Ankle kinematics (swing) 
  
≠ 
 
≠ 
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2: BACKGROUND AND LITERATURE REVIEW 
 Background content and review of the literature relevant to this study are summarized in 
this chapter.  Topics include review of AFOs and human gait for normal, pathologic and AFO 
treated individuals.   
 
2.1 AFOs 
 To understand the impact of AFOs on gait, the respective AFO treatment objectives and 
design variables of AFOs are reviewed.  
 
2.1.1 AFO Treatment Objectives 
 AFOs are rehabilitation devices used to assist gait during stance and/or swing phase. 
AFOs compensate for spasticity/weakness in the plantar/dorsiflexors and help provide both 
stability and foot clearance throughout gait. There are four potential treatment objectives for 
AFOs: 1) help re-establish an appropriate base of support, 2) control rate, excursion, and 
direction of segmental movement, 3) improve energy efficiency, and 4) help to position the foot 
for clearance and weight acceptance [2]. AFOs can restore the plantar base of support which can 
improve balance and stability, increase AFO limb single support duration, increase contralateral 
limb step length, and decrease peak plantar pressures, which in turn may facilitate increased 
activity [2]. By controlling the tibial motion throughout gait, AFOs can help to re-align the lower 
extremity (LE) and facilitate weight transfer from stance to swing. AFOs have been prescribed to 
reduce foot drop and improve foot clearance during swing phase for individuals with dorsiflexor 
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paresis, reducing compensatory gait deviations such as circumduction and vaulting [2, 4]. The 
AFO can assist foot positioning during loading response so as to restore initial heel contact. 
 
2.1.2 AFO Design Variables 
 There are various AFO designs to improve gait. For example, the rigid polypropylene 
AFO (Figure 2.1a) constrains the ankle to limit dorsiflexion or plantar flexion during stance [2]. 
The design facilitates foot clearance during mid-swing and provides foot-ankle stabilization 
during loading response [2]. The polypropylene material reduces mass with respect to metal 
designs; the reduced mass may permit prolonged patient activity without fatigue, although the 
overall strength of the AFO is reduced.  
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Figure 2.1:  Rigid polypropylene AFO (a), articulated bi-channel metal AFO (b), articulating 
polypropylene AFO (c), and DRAFO (d) (adapted from [2, 8]). 
 
To permit ankle motion, articulated AFOs may also be prescribed.  The articulated 
bichannel adjustable ankle locking AFO (Figure 2.1b) is indicated for patients with limb volume 
changes and the potential for functional improvements [2]. The bichannel ankle joints permit 
both locked (various orientations) and constrained (variable ranges of motion) options [2]. 
However, this metal AFO requires permanent integration with the shoe and therefore adversely 
affects cosmesis [2]. Articulated plastic AFOs (Figure 2.1c) may also be prescribed to permit 
c 
d 
a b 
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ankle motion in subjects who demonstrate healthy balance during gait and require less durability 
and control than provided by metal AFOs. 
An alternative non-articulated AFO, the Dynamic Response AFO or DRAFO (Figure 
2.1c), manipulates gait throughout stance phase and assists independent standing balance [9]. 
The DRAFO is composed of two separate components: a plastic rigid outer shell and a flexible 
plastic inner lining. The rigid outer shell, which includes a heel cutout, fixes the ankle in a 
plantar flexed position; heel lifts are then incorporated to vertically align the tibia during mid-
stance. This rigid shell provides protection and stability for the ankle and subtalar joints during 
gait. The inner lining, which encompasses the foot, ankle and posterior calf, protects the heel; its 
compliance provides increased proprioceptive feedback during heel contact and loading response 
[9].  
 
2.2 Normal, Able-Bodied Gait 
 To understand how AFOs affect gait, normal, no AFO gait is first reviewed. Specifically, 
the phases of gait, LE kinematics, LE muscle activity during gait, and ground reaction force 
(GRF) and joint kinetics of normal, able-bodied gait are presented. 
 
2.2.1 Phases of Gait Cycle 
 The gait cycle is defined as two successive heel strikes (HS) of the ipsilateral limb. The 
gait cycle can be divided into two periods: stance and swing.  Stance duration, which extends 
from ipsilateral HS to ipsilateral toe off (TO), is approximately 62% of the total gait cycle. 
Swing phase, defined as ipsilateral TO to ipsilateral HS, has a duration of approximately 38% of 
the gait cycle. The gait cycle can be further into five sub-phases of stance (initial contact - IC, 
8 
 
loading response - LR, mid stance - MSt, terminal stance - TSt, pre-swing - PSw) and three sub-
phases of swing (initial swing - ISw, mid swing - MSw, and terminal swing - TSw), as illustrated 
in Figures 2.2 and 2.3 [10].   
 
 
Figure 2.2: Gait cycle and relevant HS and TO events for able-bodied gait (adapted from [11]). 
 
 
 
Figure 2.3: Stance and swing sub-phases of gait (adapted from [10]). 
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Weight Acceptance 
 Stance begins with weight acceptance, a challenging sub-phase that provides shock 
absorption, initial limb stability, and preservation of progress [10]. Weight acceptance includes 
IC and LR. IC (0-2% gait cycle) begins when the foot makes contact with the floor.  During LR 
(2-12% gait cycle), body weight is transferred from the contralateral to the ipsilateral limb. At 
the end of LR, body weight is fully supported by the ipsilateral limb, initiating the first single 
limb support (SLS) phase. 
   
Single Limb Support 
 SLS includes both mid and terminal stance. This phase begins contralateral limb TO 
through contralateral limb HS; the ipsilateral limb assumes full weight-bearing responsibility. 
MSt (12-31% gait cycle) is defined from contralateral TO until ipsilateral mid- or fore-foot 
weight-bearing, providing forward progress and ipsilateral stability [10]. TSt (31-50% gait cycle) 
prepares for the transition to double limb support (DLS) and contralateral limb weight 
acceptance. TSt begins with ipsilateral heel rise to just prior to contralateral HS.  
 
Swing Limb Advancement 
 Swing limb advancement (SLA) includes PSw, initial swing, mid swing, and terminal 
swing. Pre-swing (50-62% gait cycle), the final sub-phase of stance, includes contralateral HS 
through ipsilateral TO during which weight is being transferred from the ipsilateral to 
contralateral limb.  The ipsilateral limb pushes off from the ground, providing propulsion to 
initiate swing [10]. Initial swing (62-75% gait cycle) is defined from ipsilateral foot off to until 
the foot is opposite the contralateral stance foot [10]. Mid-swing (75-87% gait cycle) then occurs 
10 
 
until the ipsilateral tibia is vertical [10]. Finally, terminal swing (87%-100% gait cycle) 
continues until the ipsilateral swing foot strikes the floor [10]. 
  
2.2.2 Lower Extremity Kinematics during Able-Bodied Gait 
 Lower extremity kinematics during gait can be described for each of the respective LE 
joints: ankle, knee and hip.  Ankle motion includes alternating periods of plantar and dorsiflexion 
(Figure 2.4).  During IC and LR, the ankle is plantar flexed. This progression from initial heel 
contact to weight acceptance is often described as the first rocker [10] during which the shank-
foot complex rotates about the heel.  During early through TSt, the tibia rotates about the ankle 
(second rocker), with the ankle transitioning to a dorsiflexed position; peak dorsiflexion occurs at 
TSt. As the contralateral limb makes contact with the ground and weight is re-distributed during 
PSw, the ipsilateral ankle begins to plantar flex.  During this transition (third rocker with mid- 
and hind-foot rotation about the metatarsal heads), peak ankle plantar flexion occurs. Ankle 
plantar flexion then decreases during swing via dorsiflexor muscle activity to provide foot 
clearance [10]. 
 Sagittal plane knee motion ranges from 0 to 60° flexion during able-bodied gait (Figure 
2.5). There are two primary periods of knee flexion, during the transition from LR to MSt to 
assist in shock absorption and weight acceptance and from TSt to initial swing to provide limb 
clearance.  
 Sagittal plane hip motion ranges from approximately 30° flexion to 10° extension (Figure 
2.6). During IC, the hip is flexed; the hip gradually extends until PSw. The hip then flexes during 
swing to advance the limb forward to prepare the limb for IC [10].  
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Figure 2.4: Sagittal plane ankle range of motion (+: dorsiflexion) during both stance and swing 
(adapted from [10]).  The sub-phases of stance (IC, MSt, TSt, PSw) and swing (ISw, MSw, TSw) 
are also noted. 
 
 
 
Figure 2.5: Sagittal plane knee ROM (+: flexion) for able-bodied gait (adapted from [10]). 
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Figure 2.6: Sagittal plane hip ROM (+: flexion) for able-bodied gait (adapted from [10]). 
 
 
 Foot progression angle (FPA), a kinematic measure that has been used to investigate knee 
moment in children and adults, varies between young able-bodied men (toe out of 7°, [10]) and 
women (toe out of 5 [10]. Another study reported mean FPA for adult men is 13-13.7° [12]. 
AFOs have been shown to increase internal FPA in children with diplegia, but not impact 
children with hemiplegia [13]. A shift towards an internal FPA may help to reduce the second 
peak knee moment and thereby reduce risk of knee osteoarthritis.  
A final kinematic or spatial parameter of gait is step width.  This measure has been used 
to study stability during walking. Similar to FPA, step width also varies with gender, ranging 
from 7 cm for young, able-bodied women to 8 cm for men [10]. Narrower step width indicates 
greater stability for a patient as they have a smaller base of support to work with, while a larger 
step width indicates instability. AFOs are prescribed to increase stability, and thereby decrease 
step width.  
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2.2.3 Lower Extremity Muscle Activity during Able-Bodied Gait 
 Lower extremity muscle activity during gait occurs primarily during the transitions from 
stance to swing and swing to stance, acting to accelerate and/or decelerate the respective limb 
segments. Key muscle groups include the dorsiflexors and plantarflexors of the ankle, the 
hamstrings and quadriceps of the knee (and hip), and the hip flexors and extensors. 
The  ankle dorsiflexors include the tibialis anterior (TA), extensor digitorum longus 
(EDL), extensor hallucis longus (EHL), fibularis longus (FL), and peroneus tertius (PT); the 
ankle plantarflexors  include the soleus, gastrocnemius, tibialis posterior, flexor digitorum 
longus, flexor hallucis longus, peroneus longus, and peroneus brevis. Dorsiflexion activity 
during gait occurs during LR to decelerate the foot and prevent foot slap and provide foot 
clearance during swing ([10], Figure 2.6). The plantar flexors are active during mid- to terminal 
stance to provide push off of the stance leg in preparation for swing ([10], Figure 2.7). 
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Figure 2.7: Surface EMG activity of the ankle dorsiflexors during able-bodied gait (adapted from 
[10]). (IC, LR, MSt, TSt, PSw, ISw, MSw, TSw) 
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Figure 2.8: Surface EMG activity of the plantar flexors during able-bodied gait  
(adapted from [10]). 
 
 
The knee extensor muscles consist of the vastus intermedius, vastus lateralis, vastus 
medialis, and rectus femoris (Figure 2.9). The knee flexors consist of the biceps femoris, 
popliteus, gastrocnemius, semimembranosus, semitendinosus, gracilis, and sartorius (Figures 
2.10, 2.11, 2.12). The knee extensors are active during early stance and terminal swing to 
provide stability to the knee and prepare for weight bearing, respectively. The knee flexors are 
active during initial and mid-swing to assist with clearance. 
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Figure 2.9: Surface EMG activity of the knee extensors during able-bodied gait (adapted from 
[10]). 
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Figure 2.10: Surface EMG activity of the hamstrings during able-bodied gait  
(adapted from [10]). 
 
 
 
Figure 2.11: Surface EMG activity of the knee flexors during able-bodied gait  
(adapted from [10]). 
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Figure 2.12: Surface EMG activity of the gracilis (knee extensor) and sartorius (hip and knee 
flexor) during able-bodied gait (adapted from [10]). 
 
 
The hip extensor muscles consist of the hamstrings (semimembranosus, biceps femoris, 
and semitendinosus), adductor magnus, and gluteus maximus (Figure 2.13). These muscles are 
active from terminal swing through LR to advance the lower limb in preparation for stance. The 
hip flexors include the gracilis, rectus femoris, sartorius, and iliacus; these muscles are active 
primarily from late stance through early swing (Figure 2.15) to keep the trunk stable during SLS.  
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Figure 2.13: Surface EMG activity of the hip extensors during able-bodied gait  
(adapted from [10]). 
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Figure 2.14: Surface EMG activity of the hip flexors during able-bodied gait (adapted from [10]). 
 
 
2.2.4 Ground Reaction Force Kinetics during Able-Bodied Gait 
 The kinetics of gait are quantified in terms of the GRF or superior-inferior, medial-
lateral, and fore-aft forces under the foot.  These forces are located at the center of pressure 
(COP, Figure 2.15).  Both the GRFs and the progression of the COP are used to characterize the 
kinetics of able-bodied gait and differentiate pathologic gait. 
The superior-inferior or vertical GRF during able-bodied gait is characterized by two 
peaks (approximately 110% body weight), separated by a valley (Figure 2.16).  The first peak 
occurs between LR and MSt and is attributed to weight transfer during SLS [10]. The second 
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peak, F3, occurs during TSt and is attributed to plantarflexion push off and the downward 
acceleration of the center of gravity (COG) as the body weight falls over the forefoot rocker.   
The valley or local minima occurs due to the rise of the COG as the body rolls over the 
ipsilateral stance foot. 
The medial-lateral and fore-aft forces are smaller in magnitude. The peak medial-lateral 
force occurs during LR, a braking response of the body [10]. The fore-aft GRFs peak during 
early stance with an anterior force due to body weight loading. During TSt, the fore-aft forces are 
posterior reflecting push off or propulsion into swing [10].   
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Figure 2.15: COP progression projected onto the right foot from HS-TO.  The long axis of the 
foot (blue line), from the posterior heel to the second metatarsal head, is also shown (adapted 
from [10]). 
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Figure 2.16: GRFs: superior-inferior (top), medial-lateral (middle), and fore-aft (bottom) 
directions (adapted from [10]). 
 
 
2.3 AFO-treated Gait 
 AFOs are used to compensate for weak dorsiflexors, hyperactive plantarflexors, or 
impaired lower extremity function. The rigid plantar structure of AFOs provides a stable base of 
support for the foot. AFOs have been shown clinically to restore function, increase walking 
speed, decrease energy cost ([14], Table 2.1), reduce knee hyperextension ([15], Table 2.2), or 
increase peak knee extensor moments ([16], Table 2.2). Motion analysis research studies have 
demonstrated decreased kinematic pathologies, decreased spasticity in terms of EMG activity, 
and reduced pathologic GRFs with AFO use.  
Superior-inferior 
Medial-lateral 
Fore-aft 
24 
 
 
2.3.1 Clinical Functional Outcomes with AFO Use 
 The efficacy of various AFO designs has been investigated to confirm whether the 
prescribed AFO addressed the specific treatment objectives and to assess specific functional 
outcomes, largely with respect to gait (Table 2.1). Clinical tests and metrics have included: the 
timed up and go test (TUG), stability assessment [Berg Balance scale (BBS)], cadence and self-
selected walking speed (SSWS), and metabolic cost (oxygen consumption or energy cost). 
 The TUG test measures a person’s ability to stand up, walk three meters, walk back, and 
sit down in terms of task completion time. For post-stroke individuals, TUG completion time 
increased with increasing level of disability [17-19]. TUG time was observed to decrease by 3-6 
sec with AFO use [15, 17]. 
The effects of AFO use on balance and stability during ambulation and various activities 
of daily living for static and dynamic tasks have been assessed using the BBS (Table 2.1). The 
BBS assesses balance during 14 tasks relevant to activities of daily living (e.g. sit to stand), with 
scores ranging from 0 to 4 and higher scores reflecting improved balance and functional 
independence [20]. Use of a custom metal or plastic AFO resulted in improved BBS scores with 
respect to the no AFO condition for individuals post-stroke (AFO: 48.0±4.8 vs no AFO: 
46.2±5.5) [18]. Wang et al., however, reported no change in BBS scores for post-stroke 
individuals using standard off-the-shelf plastic, non-articulated AFOs [21]. These differences in 
functional improvement may be attributed to the specific AFO used. 
The effects of AFO use on spatial-temporal parameters such as cadence and SSWS have 
also been investigated for post-stroke individuals. SSWS has been reported to increase with AFO 
use relative to the no AFO condition (0.34 m/s vs 0.27 m/s) [14]. The time required to complete 
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a 10m walk has been shown to decrease with AFO usage for post stroke individuals, again 
reflecting increased walking speed with AFO use [19]. 
Finally, the clinical effect of AFO usage on metabolic cost has been measured on 
individuals with cerebral palsy (CP), as well as post stroke subjects. Metabolic cost has been 
assessed in terms of both oxygen consumption (volume of oxygen consumed per minute of 
ambulation) and energy cost (oxygen consumption normalized to distance traveled). Net oxygen 
uptake and net pulmonary ventilation were reduced (5.9-8.9% and 10.3%, respectively) with 
AFO use for individuals with CP [22].   Similarly, oxygen consumption decreased from 0.52 to 
0.46mL/kg-m with AFO use for post stroke subjects while the physiological cost index decreased 
from 0.75 to 0.73 [23]. 
 
2.3.2 Motion Analysis Investigations of AFO Use 
The effect of AFO use on gait has also been investigated using motion analysis (Table 
2.2). Ankle orientation in rigid AFOs has been shown to affect joint kinematics and kinetics, 
with plantarflexed AFOs resulting in decreased knee flexion moment, or increased knee stability 
during LR for post-stroke individuals [6]. Shorter foot plates decreased ankle dorsiflexion during 
both stance and swing for able-bodied subjects with AFO use [16]. The effects of AFO 
alignment (heel wedges) and shoe sole stiffness on knee kinematics have also been investigated.  
Both the inclusion of a heel wedge and a stiff rocker sole reduced knee hyperextension for a 
single post stroke subject wearing a plastic, non-articulated AFO [15]. 
In contrast to traditional kinematic analysis of the ankle, knee, and hip joints, Owen 
investigated the effects of AFO design on segment kinematics in terms of shank-to-vertical angle 
(SVA) and thigh-to-vertical angle (TVA) (Figure 2.17 and 2.18). These angles are reported 
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relative to a global coordinate system (e.g. vertical or gravity reference) rather than a local, 
segment-based coordinate system. The global reference system was thought to have clinical 
value with respect to AFO alignment and observational gait analysis. A common clinical 
misconception is that the shank and thigh are concurrently vertical during MSt (MSt) [24]. 
Coincident vertical segments would result in knee and ankle instability, requiring forward trunk 
lean posture or a reclined thigh with trunk lean to impose hip and knee flexion [24]. The SVA 
during MSt was modified via AFO alignment variations to investigate the effects of AFO 
alignment and SVA angle on the gait of a post stroke subject. Nominal AFO alignment and 
footwear resulted in a SVA of 0° (e.g. vertical shank) during MSt. Inclusion of heel wedges 
resulted in a SVA of 14° (e.g. inclined shank) during MSt, thereby decreasing knee 
hyperextension during MSt [15]. 
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Figure 2.17: Comparison of joint (knee and ankle) and segment (SVA and TVA) angles, defined 
in local and global coordinate systems, respectively. 
 
 
 
Figure 2.18: Lower limb segment angles from heel strike through toe off, illustrating the shank 
and thigh segment orientations (e.g. reclined: -, inclined: +). 
 
The effect of AFO design on lower extremity muscle activity has also been investigated, 
as AFOs are often prescribed to address muscle weakness and/or spasticity [4, 5]. Dorsiflexor 
activity has been shown to decrease during LR for both post-stroke (7% decrease) and able-
bodied (20% decrease) individuals with AFO use, as non-articulated AFOs restrict ankle plantar 
flexion and minimize the need for dorsiflexor activity during MSt to prevent foot slap [4, 5].  
28 
 
The fixed neutral ankle position in these solid AFOs also reduced dorsiflexor activity during 
swing for post-stroke subjects [4, 5]. 
Finally, the effect of AFOs on gait kinetics has been investigated in terms of joint 
moments and sway of the COP. Full-length foot plates significantly increased peak plantar flexor 
moment during stance for both post-stroke and able-bodied individuals [16]. COP sway in both 
the medial-lateral and fore-aft directions was reduced by 23-26% for able-bodied individuals 
with AFO use during standing balance trials [25]. 
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Table 2.1: Summary of functional outcomes with AFO use as reported in the literature.  
Investigators Subjects AFO Type Metrics 
Danielsson and 
Sunnerhagen, 2004 [14] 
Hemiparetic (N=10) Carbon composite AFO 
Walking speed, oxygen 
consumption, heart rate, energy 
cost 
Danielsson, et al,, 2007 
[26] 
Hemiparetic (N=20) and healthy 
aged 30-63 (N=16) 
Unspecified 
Oxygen consumption and energy 
cost 
de Wit, et al., 2004 [17] Chronic post stroke (N=20) Polypropylene rigid AFO Walking speed, TUG 
Maltais, et al., 2001 [22] Splastic diplegic CP (N=10) Hinged AFO Oxygen consumption 
Ng and Hui-Chan, 2005 
[18] 
Healthy elderly  (N=11), and 
chronic post stroke (N=10) 
Unspecified 
Spasticity of plantaflexor, MVIC, 
6 minute walk test, TUG test 
Simons, et al., 2009 [18] Acute Stroke (N=20) 
Polypropylene rigid AFO or articulated 
metal AFO 
BBS, TUG, 10 m walking test 
Wang et al.,  2005 [21] 
Hemiparetic short term (N=42) 
and long term (N=61) 
Polypropylene AFO BBS, 10 m walking test 
MVC = maximum voluntary contraction 
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Table 2.2: Summary of research studies assessing AFO function. 
Investigators Subject AFO Type Metrics 
Cruz and Dhaher, 2009 [3] Hemiplegic (N=9) Polypropylene rigid and articulating 
AFOs 
LE kinematics, temporal 
parameters 
Fatone et al., 2009 [16] Post stroke (N=16), 
normal (N=12) 
Polypropylene articulating AFO LE Kinetics: knee, ankle 
moment, LE Kinematics: 
knee, ankle angles 
Geboers et al., 2002 [43] Normal (N=14) 
and foot drop 
(N=29) 
Polypropylene rigid AFO or self-
selected 
Dorsiflexion EMG 
Jagadamma et al., 2010 [15] Hemiplegic (N=1) Polypropylene rigid AFO LE Kinetics: knee moment, 
LE Kinematics: knee angle 
and SVA 
Lairamore et al.,  2011 [5] Post stroke (N=15) Polypropylene rigid AFO Dorsiflexion EMG 
Silver-Thorn, et al., 2011 [6] Post stroke (N=8) Polypropylene rigid AFO velocity, cadence, step length, 
LE Kinetics: knee moment 
Vistamehr, et al., 2014 [8] Normal (N=10) Polypropylene rigid AFO Propulsive impulses, angular 
momentum 
Warnica, et al., 2014 [25] Normal (N=18) Nylon rigid AFO Kinetics: COP, kinematics: 
whole body, dorsiflexion and 
plantarflexion EMG 
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2.4 Summary 
 AFOs are assistive devices prescribed to provide support for the foot throughout the gait 
cycle and to provide proper foot clearance during swing phase. Depending on the impairment, a 
rigid or an articulating AFO may be prescribed. Rigid AFOs provide greater stability for those 
with higher levels of impairment or older populations, while the articulating AFOs provide 
limited movement which may aide recovery and prevent muscle atrophy.   
Pathologies requiring AFO intervention have been shown to adversely affect walking 
speed, balance/stability, kinematics, EMG activity, and kinetics of gait. Pathologies such as 
stroke and CP can cause dorsiflexion weakness, affecting toe clearance during swing phase. 
Pathologies and injuries may also lead to compensatory mechanisms, such as hip hiking, 
vaulting, and circumduction, which can lead to further injuries or increased energy expenditure 
during gait. 
 AFO usage has been shown to improve clinical functional outcomes and gait measures 
compared to no AFO gait in pathologic subjects. AFO usage has been shown to decrease TUG 
completion times and increase BBS scores, reflecting improved stability when walking with an 
AFO; walking speed has also been observed to increase with AFO use. Finally, AFO use has 
reduced compensatory motion of the knee and ankle, decreased dorsiflexor and plantarflexor 
EMG activity, and reduced COP sway. 
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Chapter 3: METHODS 
 This study involved gait analysis of able-bodied individuals during level treadmill 
ambulation to contrast unassisted versus AFO (non-articulated rigid, articulated and DRAFO 
designs) gait.   The research hypotheses (see Table 1.1) were: 1) DRAFO-assisted gait will 
approximate that of the non-AFO condition, and 2) DRAFO-assisted gait will differ from that for 
articulating and rigid AFOs. To test these hypotheses, sagittal plane knee/ankle angles, 
shank/thigh to vertical angles (SVA/TVA), plantar/dorsiflexion muscle activity duration, and 
COP progression were contrasted for the various AFO conditions. 
 This chapter details the procedures for gait analysis including: subject selection, AFO 
casting/fabrication/fitting, and static/dynamic gait analysis.  Details regarding the subsequent 
data processing for kinematic, EMG, and kinetic data are also included, as are the respective 
statistical analyses. 
 
3.1 SUBJECT SELECTION 
3.1.1 Inclusion Criteria 
 The study protocol was approved by the Institutional Review Board (IRB) of Marquette 
University. Ten young healthy subjects, undergraduate and graduate students in biomedical 
engineering at the University, were recruited. Subject selection criteria were: 
 18-25 years of age, 
 normal dorsi-/plantar flexion range of motion and strength, and 
 capable of attaining a passive 90° neutral ankle position. 
Subjects with prior musculoskeletal injury or deformity of the lower extremities were excluded. 
 
33 
 
3.1.2 Subject Recruitment 
 Subjects were recruited via fliers posted in prominent locations in University engineering 
buildings and by word of mouth. Interested individuals were screened to confirm eligibility. 
Written informed consent was obtained prior to research participation. 
 
3.2 TESTING PROTOCOL 
3.2.1 AFO Casting and Fabrication 
 During an initial 60 minutes research session, a certified orthotist (Davin Amara, C.O., 
Bracemasters International, LLC, New Berlin, WI) casted the subject’s right leg from the toes to 
just distal to the knee. The ankle was held at 90° neutral orientation until the cast set. This cast 
served as a negative mold, and used to create a positive model of the lower leg for fabrication of 
the custom AFOs. For each subject, two AFOs were fabricated by Bracemasters: an articulating 
AFO with Tamarack flexion joints with a locked ankle joint option, and the DRAFO aligned at 
3° plantarflexion as per clinical guidelines (Figure 3.1). The outer shells of the articulating AFO 
and DRAFO were fabricated with a polypropylene co-polymer with modified polyethylene 
dynamolene; the flexible inner lining of the DRAFO was fabricated using dynamolene.  When 
wearing the DRAFO, external lifts were secured to the soles of the subject’s shoes to align the 
shank vertically during MSt. 
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Figure 3.1: Articulating AFO (left) and DRAFO (right). 
 
3.2.2 Gait Analysis 
3.2.2.1 Subject Instrumentation and Marker Placement 
 A second research session, approximately 2 hours in duration, was conducted in Dr. 
Hyngstrom’s Neurolocomotion Lab at Marquette University. Anthropometric measurements of 
the subject’s knee width, ankle width, and leg length were acquired; the subject’s height and 
weight were also recorded [27].  These measurements were requisite input to the Plug-In-Gait 
(PIG) model (Nexus v 1.8.1, Vicon Motion Systems, Inc, Lake Forest, CA, 2002). 
 The skin over the subject’s anterior shanks and posterior calves was cleaned with rubbing 
alcohol prior to applying conductive gel and placing bipolar surface EMG electrodes (MA-411 
EMG with preamplifier, Motion Lab Systems, Baton Rouge, LA) to acquire tibialis anterior (TA) 
and gastrocnemius (G) muscle activity. A similar procedure was used to apply a ground 
electrode over the bony prominence of the subject’s proximal tibial flare. These electrodes were 
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secured with hypoallergenic tape and wrapped with Coban tape (COBAN Technologies, 
Houston, TX) to minimize potential motion artifact. 
 Fifteen reflective markers (14mm) were then secured over specific bony landmarks using 
double sided tape [27]. Marker locations included: the sacrum, as well as right and left anterior 
superior iliac spines (ASIS), lateral thigh, approximated knee joint center, lateral shank, lateral 
malleolus, second metatarsal head (on shoe), and heel (on shoe).  Four additional markers were 
placed on each shoe at the medial and lateral midfoot to aid COP referencing (see Figure 3.2). 
The subject was then secured in an overhead harness system to minimize risk of injury in case of 
fall. 
 Nexus (version 1.8.1, Vicon Motion Systems, Inc) was used to capture the kinematic data 
at 100 Hz. Six to eight (two additional laboratory cameras were added to the motion capture 
system mid-study) infrared cameras were used to capture the trajectories of the reflective 
markers. The four EMG channels were sampled at 1000 Hz. The kinetic data from the 
instrumented, split-belt treadmill (Bertec, Columbus, OH) were sampled at 1000 Hz. All data 
were synchronously acquired on a single computer. 
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Figure 3.2: Subject wearing the DRAFO, instrumented with reflective 
markers and surface electrodes, during treadmill walking. 
 
3.2.2.2 Static Trial 
 Initial static trials were recorded for each subject to validate marker placement, define 
segments, and acquire maximum voluntary contraction (MVC) EMG activity of the two muscle 
groups bilaterally. A single MVC of 3-5 seconds was solicited for the right TA, right G, left TA, 
and left G as the subject stood, dorsiflexing against manual resistance or plantar flexing against 
the treadmill surface.  
A preliminary kinematic PIG model was then created, defining the respective pelvis, 
thigh, shank, and foot segments in terms of the markers. The pelvis was defined by the two ASIS 
and sacrum markers. The thigh was defined by the respective ASIS, knee center, and thigh 
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markers. The shank was defined by the respective knee center, malleolus, and shank markers. 
Lastly, the foot segment was defined by the respective malleolus, heel and 2nd metatarsal head 
markers. Marker locations were adjusted as needed, repeating the static trials, prior to dynamic 
gait trials. 
 
3.2.2.3 Dynamic Gait Trials 
 Dynamic gait trials were conducted for all test conditions: no AFO condition, followed 
by randomized testing of the rigid, articulated and DRAFO conditions.  
The subject acclimated to the treadmill for approximately 5 minutes, identifying their 
self-selected walking speed (approximately 1.0 m/s).  Marker positions and EMG signals were 
visually verified during this period.  Two minute walking trials at the subject’s self-selected 
walking speed were then conducted; kinematic, EMG and kinetic data were acquired for six 20-
second periods. The AFO for the respective test condition was then removed. 
The shank and lateral malleolus markers of the right leg were removed.  The AFO for the 
next test condition was then donned. Static trials were repeated for the new AFO condition. The 
subject acclimated (up to 5 minutes) to the new AFO during overground walking.  Dynamic gait 
trials were then conducted.  This procedure was repeated for each of the three AFO conditions. 
 
3.3 KINEMATIC DATA PROCESSING 
 The kinematic data were first processed using Nexus. The c3d files were imported into a 
library, prior to reconstruction and editing. Processing steps included correcting mislabeled 
markers and filling gaps due to marker drop out. Further processing was then conducted using 
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MatLAB (The Mathworks Inc., Natick, MA) scripts to calculate mean sagittal plane joint angles 
for the knee and ankle, as well as shank and thigh vertical angles.  
 
3.3.1 Construction of 3D Motion Data 
 The 2D marker data from each camera were processed through direct linear 
transformation to create 3D marker motion trajectories. Using the static trial data, the markers 
were labelled. Marker trajectories were reviewed to identify potential mislabelling, correcting as 
needed. Marker gaps (less than 50 consecutive frames) due to drop out were filled using spline 
filtering. Phantom, unlabelled markers were removed.  Marker trajectories were smoothed using 
a Woltring filter. 
 
3.3.2 Calculation of Conventional Lower Extremity Joint Angles 
 To determine joint angles, limb segments were defined from the various marker sets, as 
noted in the Static Trials section. The respective joint centers were then identified using the PIG 
model. The hip joint center was calculated based on leg length and inter-ASIS distance; the knee 
joint center was calculated using the hip joint center, thigh marker, and knee center marker; the 
ankle joint center was calculated from the knee joint center, shank marker, and malleolus marker 
(with ankle offset for the right limb, if an AFO condition) [27].  
To facilitate kinematic comparison between AFO conditions, the sagittal plane knee and 
ankle angles were reviewed to determine the knee and ankle angles during various periods of 
stance and swing. For the knee, the periods of interest included IC, early stance (0-30% of gait 
cycle), mid- to late-stance (30-70% gait cycle), and swing.  The specific knee metrics were: 1) 
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knee angle at IC, 2) peak knee flexion during early stance, 3) peak knee extension during mid- to 
late-stance, and peak flexion during swing. For the ankle, the periods on interest corresponded to 
the three rockers [e.g., early stance (0-30% gait cycle, heel rocker), mid- to –terminal stance 
(ankle rocker), late stance (toe rocker)] and swing.  The specific ankle kinematic measures were: 
peak plantarflexion during early stance (first rocker), peak dorsiflexion during mid- to late-stance 
(second rocker), peak plantarflexion during late-stance (third rocker), and peak dorsiflexion 
during swing. 
 
3.3.3 Calculation of Non-Conventional Segment Angles, SVA and TVA 
 Two additional angles were calculated in this study: shank to vertical (SVA) and thigh to 
vertical (TVA) segment angles, both defined with respect to a global, laboratory-based 
coordinate system.  The SVA refers to the angle between the shank and the global z-coordinate 
(vertical); similarly, the TVA refers to the angle between the thigh and the global z-coordinate 
(Figure 2.17). These angles were calculated in MatLAB; the SVA was calculated using the 
location of the ankle center of rotation and tibial segment orientation; the TVA was calculated 
using the knee center of rotation and thigh segment orientation. The time at which the SVA and 
TVA transitioned from extended to flexed positions and vice versa, e.g. crossover time or time 
(percent gait cycle) when SVA=0° and TVA=0°, were also recorded (Figure 3.3). 
 
 
40 
 
 
Figure 3.3: Sample kinematic data for subject 3 (no AFO condition) illustrating ankle and knee 
joint angles (gray), SVA and TVA (black), and SVA and TVA cross-over times (X). 
 
3.3.4 Calculation of Foot Progression Angle 
 The FPA, the final kinematic parameter investigated in this study, was defined as the 
angle between forward progression and the long axis of the foot (heel to toe marker) in the 
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transverse plane. Positive angles were defined as external rotation or toe out; sample data are 
shown in Figure 3.4. 
 
 
Figure 3.4: Sample foot progression angle, mean (black) and standard deviation (gray), in the 
transverse plane (subject 5, no AFO condition). 
 
 
3.4 CALCULATION OF TEMPORAL PARAMETERS 
 Heel strike (HS) and toe off (TO) events were identified to differentiate stance and swing 
phases of gait. Specific event detection was based on vertical GRF data from the instrumented 
treadmill.  HS and TO events were defined as the instance when the vertical forces exceeded or 
fell below 4% of the maximum vertical GRF, respectively. Each gait cycle was defined from 
successive ipsilateral HS events; stance was defined from successive ipsilateral HS to ipsilateral 
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TO events and swing was defined as successive ipsilateral TO to ipsilateral HS events (Figure 
3.5). 
 
 
3.4.1 Step Width 
 Using the HS events and the position of the heel markers, step width was calculated as 
the mediolateral distance between the heel markers of the left and right feet.  
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Figure 3.5: Sample vertical GRF data for the right (red) and left (black) 
limbs for subject 3 (no AFO condition), illustrating HS and TO event 
detection via a threshold detection algorithm. The blue shaded region is 
right stance; the green shaded region is right swing.   
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3.5 EMG DATA PROCESSING 
 All EMG signal processing was conducted in MatLAB. The TA and G surface EMG data 
for both limbs were rectified, low pass filtered and segmented into gait cycles based on the HS 
and TO events; data were then scaled. Finally, EMG data were reviewed during the stance and 
swing phases of gait to identify the activation periods. 
 
3.5.1 Rectification and filtering of EMG data 
The EMG waveform was full-wave rectified (absolute value) and smoothed (second 
order, low pass, Butterworth filter at 5Hz) to create a linear envelope, Figure 3.6. 
 
 
Figure 3.6: EMG post-processing for representative TA data (subject 8 wearing DRAFO): a) 
raw EMG, b) rectified EMG, c) rectified and low-pass filtered EMG, and d) rectified, 
filtered, and normalized EMG. 
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3.5.2 Normalization or scaling of EMG data 
The EMG waveforms were then scaled based on the respective EMG magnitude observed 
during the maximum voluntary contraction (MVC) trial. To determine the MVC magnitude for 
each subject and muscle, the mean baseline EMG level during off period was subtracted from the 
mean EMG level during the MVC activation period (Figure 3.7). During the dynamic tasks, the 
rectified, filtered EMG data were then normalized or scaled based on the respective mean MVC 
magnitude (Fig 3.6d). 
 
 
Figure 3.7: MVC trial for dorsiflexion (subject 3, no AFO condition) illustrating mean 
baseline and mean MVC activation magnitude and duration. 
 
3.5.3. Identification of muscle activation periods 
 The rectified, filtered, and normalized EMG waveforms were divided into individual gait 
cycles, stance and swing phases based on synchronously acquired GRF data and the HS and TO 
events. These EMG subsets were reviewed to identify muscle activation periods based on 
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amplitude threshold analysis. Periods for which EMG values exceeded this threshold were 
considered “on” or active; periods for which EMG values were less than the threshold were 
considered “off” or inactive.  
Investigation of the amplitude threshold level (20-40% MVC) was conducted to identify 
the normalized EMG amplitude threshold for the no AFO condition that resulted in activation 
periods consistent with able-bodied data [10]. An activation threshold of 20% MVC was selected 
after comparing dorsiflexor and plantarflexor activation periods for the no AFO condition in this 
study to Perry’s EMG activity (Figures 2.7, 2.8, 3.8, and 3.9, [10]).  
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Figure 3.8: Sample activity duration of the dorsiflexors (top - stance: black, swing: dark gray) 
and plantarflexors (bottom, stance only) for subject 3 (no AFO condition) and for able-bodied 
persons (Perry), assuming an activation threshold of 20% [10]. 
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Figure 3.9: Representative dorsiflexion (top) and plantarflexion (bottom) EMG activity time 
series with corresponding on-periods based on activation thresholds of 20 (black), 30 (gray), and 
40% (light gray) for subject 3 (no AFO condition).   Also shown is the approximate activation 
periods for able-bodied subjects from Perry (red) [10]. 
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This activation threshold of 20% MVC was then applied to the bilateral EMG data for 
both the plantar flexors and dorsiflexors for all gait cycles to differentiate the active and inactive 
periods, as well as the duration of the activation periods during stance and swing, for each AFO 
condition for each subject.  The total activation period duration during stance (and similarly, 
during swing) was calculated as the sum of all activation periods during stance for each gait 
cycle.  The mean activation period duration during stance (and similarly, during swing) was 
calculated across all gait cycles for the respective subject and AFO condition. 
 
 
 
3.6 COP DATA PROCESSING 
 The COP defines the location of the GRF relative to either a global, laboratory-based 
coordinate system or a local coordinate system such as the foot. Motion of the COP, in terms of 
the length of the COP trajectory or its anterior-posterior and medial-lateral displacement, is often 
used to characterize stability during gait or quiet standing. This section details specific kinetic 
and kinematic data processing to investigate COP progression relative to a local coordinate 
system defined by the foot, as well as the global, laboratory-based coordinate system. 
 
3.6.1 Calculation of COP progression 
 The COP of the right and left limbs was initially evaluated using the global, laboratory-
based coordinate system of the treadmill, as shown in Figure 3.11. The COP, the location of the 
GRF vector relative to the treadmill, was defined using Equations 1 and 2 [28]:  
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Figure 3.10: Global coordinate system for COP determination (adapted from [28]). 
 
                                            𝑥𝑝 =
−ℎ∗𝐹𝑥−𝑀𝑦
𝐹𝑧
                          (1) 
                                            𝑦𝑝 =
ℎ∗𝐹𝑦−𝑀𝑥
𝐹𝑧
    (2) 
where xp, yp are the COP locations in the x-y or transverse plane, h is distance between the 
treadmill belt and the embedded load cells (e.g. 0.015 mm), and Fi and Mi are the force and 
moment components. 
To express the COP in terms of a local, foot-based coordinate system, a pseudo-foot was 
defined in terms of the foot markers (Figure 3.11). This pseudo-foot used the heel marker and the 
medial and lateral shoe markers to define the boundaries of the foot. The alignment of the long-
axis of the foot, relative to the global coordinate system, was defined by the angle θ using 
Equation 3. 
𝜃 = atan⁡(
𝑅𝐻𝑒𝑒𝑥−𝑅𝑇𝑜𝑒𝑥
𝑅𝑇𝑜𝑒𝑦−𝑅𝐻𝑒𝑒𝑦
)    (3) 
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where RHee and RToe refer to the right heel and toe marker positions in the global coordinate 
system.  
To transform the COP from the global coordinate system (x, y) to the local, foot-based 
coordinate system (xf, yf), the above rotation with respect to the angle, , was translated from the 
treadmill origin to the heel (Figure 3.10), as described by Equations 4-5. 
𝑥𝑓 = 𝑥 ∗ 𝑐𝑜𝑠(𝜃) − 𝑦 ∗ 𝑠𝑖𝑛(𝜃)   (4) 
𝑦𝑓 = 𝑥 ∗ 𝑠𝑖𝑛(𝜃) + 𝑦 ∗ 𝑐𝑜𝑠(𝜃)    (5) 
To characterize the progression of the COP during stance, the medial-lateral motion relative to 
the long-axis of the foot was quantified (Fig 3.11 and Fig 3.12).  Specifically, at a given instance 
in stance, the global heel marker position was transformed to the local foot-based coordinate 
system; the location of the local COP relative to the heel was translated such that the COP was 
located at the heel at IC.  As stance progressed, COP locations with positive xf values 
corresponded to COP being lateral to the long axis of the (right) foot; negative xf corresponded to 
the COP being medial to the long axis of the (right) foot. 
The medial and lateral motion of the COP (e.g. minimum, maximum, range, and mean 
values) was then calculated for the various sub-phases of stance: LR, MSt, TSt, and PSw for 
each subject and AFO condition. Outlier values that exceeded the foot width or were in excess of 
±2 standard deviations of the mean were excluded from analysis.  
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Figure 3.11: Pseudo-foot with medial/lateral shoe, toe, and heel markers in the transverse 
plane demonstrating the transformation (rotation followed by translation) from the global, 
treadmill-based coordinate system (x-y or transverse plane) to the local, foot-based 
coordinate system (xf-yf).  
y 
x 
yf 
xf 
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Figure 3.12: (top) Transverse plane motion of the heel (blue), medial (red), and lateral midfoot 
(green) marker positions during a sample gait cycle (subject 3, no AFO condition); also shown is 
the COP trajectory (black).  The mean motion of the COP relative to the local foot-based 
coordinate system is shown in (bottom), from heel strike (o) to toe off (x).  
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3.7 STATISTICAL ANALYSES AND HYPOTHESIS TESTING 
 Statistical analyses were performed both to assess parameter power and future sample 
population size, as well as to contrast the measures for the various AFO conditions and 
investigate the research hypotheses.   
 
3.7.1 Power Testing 
 Post hoc power analyses were performed for each of the measured kinematic, EMG and 
kinetic parameters. The post hoc power analyses were performed as two-tailed t tests, with the 
specific statistical test being “Means: Difference between two dependent means (matched 
pairs)”. The effect size was based on the mean and standard deviation for the respective 
parameters using a correlation of 0.5. The α value was set at 0.05 and sample size was the 
number of subjects in this study, n=10 (GPower v 3.1, Heinrich-Heine-Universität Düsseldorf). 
The respective parameter results were analyzed post hoc to estimate recommended population 
sizes for future studies. 
 
3.7.2 Hypothesis Testing 
 The normality of the data parameters (joint and segment angles, EMG activity duration, 
medial-lateral COP motion) was tested to determine whether subsequent parametric or non-
parametric analysis should be conducted to investigate the research hypotheses. Normality 
testing was conducting using the normality feature of Minitab (v17, Minitab Inc, State College, 
PA).  Normally distributed data were reviewed using the General Linear Model feature to 
identify significant parameter differences. If observed significant differences in a given 
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parameter were identified, Tukey’s post hoc test was then performed to assess differences 
between the various AFO conditions and test the corresponding research hypotheses (e.g. 
Hypothesis 1: ankle kinematics during LR with the DRAFO approximate that of the no AFO 
condition; Hypothesis 2: ankle kinematics during LR with the DRAFO differ from both the free 
and rigid AFOs).  Similarly, non-normally distributed data were reviewed using Friedman’s test. 
Subsequent post-hoc testing was conducted using Wilcoxon Signed Rank tests to assess 
differences between the various AFO conditions and test the related research hypotheses.   
 
3.8 SUMMARY 
 Able-bodied subjects were recruited to contrast various AFO conditions during treadmill 
walking.  Data included kinematic (joint and segment angles, crossover times), EMG 
(plantar/dorsiflexor activity duration during both stance and swing), and kinetics (medial and 
lateral motion of the COP during the sub-phases of stance). Data were segmented into gait cycles 
and respective parameter values were contrasted using statistical analysis to test the research 
hypotheses, namely that DRAFO-gait approximated no AFO gait and that DRAFO-gait differed 
from free/rigid-AFO gait. 
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Chapter 4: RESULTS 
 Ten young, able-bodied subjects were recruited and completed gait analyses for all test 
conditions: no AFO, DRAFO, free AFO, and locked AFO. Acquired data included bilateral 
lower extremity joint and segment kinematics, EMG activity duration of the ankle plantarflexors 
and dorsiflexors, and GRF and COP data. The various time series were segmented into stance 
and swing periods, as well as single and double support periods, based on HS and TO events. 
These data were contrasted for the four AFO test conditions to test the research hypotheses 
detailed in Table 1.1, namely that the DRAFO condition would approximate the no AFO 
condition, and that the DRAFO condition would differ from the free and locked AFO conditions. 
 
4.1 SUBJECT INFORMATION 
 Ten young, able-bodied subjects were recruited as per the selection/exclusionary criteria, 
and completed level treadmill walking trials and gait analyses in the four AFO test conditions.  
These subjects and their anthropometric data are summarized in Table 1.  
 
Table 4.1: Summary of subject details and anthropometry. 
Subject Gender Age 
(yrs) 
Height 
(m) 
Weight 
(kg) 
Lower Limb 
Length (mm) 
1 F 20 1.52 89.8 830 
2 F 20 1.73 53.5 920 
3 F 20 1.60 63.5 852 
4 M 21 1.80 77.1 936 
5 M 19 3.64 65.8 981 
6 F 22 1.71 56.3 928 
7 F NA 1.73 65.8 910 
8 M 22 1.72 78.9 863 
9 F NA 1.70 86.2 773 
10 M 20 1.83 72.6 970 
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4.2 LOWER EXTREMITY JOINT and SEGMENT KINEMATICS 
 One objective of this study was to investigate the effects of AFO design on lower 
extremity joint and segment kinematics. Related measures included knee and ankle joint motion 
in the three planes, as well as the corresponding thigh and shank segment sagittal plane angles 
relative to vertical (e.g. TVA and SVA).  The related research hypotheses were: 1) DRAFO-
assisted gait parameters (e.g. ankle plantarflexion during early stance, cross-over times of the 
shank and thigh vertical angles during stance, step width, dorsiflexion activity during early 
stance, and center of pressure progression during LR) will approximate that of the no AFO 
condition and 2) DRAFO-assisted gait parameters (e.g. ankle and knee kinematics, cross-over 
times of the shank and thigh vertical cross over times during stance, peak foot progression angle 
during stance, step width, stance phase dorsiflexion activity duration, and mediolateral motion of 
the COP) will differ from that for locked and articulating AFOs. 
 
4.2.1 Knee Angle and Thigh to Vertical Angle (TVA) 
   Representative plots of mean sagittal plane knee angle and TVA across the gait cycle 
are shown in Figure 4.1. These curves illustrate that the subject demonstrated knee flexion during 
early stance, with peak knee flexion occurring during swing, as common for able-bodied gait. 
While few changes in knee angle were observed between the no AFO, free AFO and locked 
AFO conditions for this subject, the DRAFO affected knee flexion angle at heel strike and during 
early stance.  
To facilitate kinematic comparison between AFO conditions, the sagittal plane knee 
angle was reviewed to determine peak values and ranges of motion during various periods of 
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stance (IC, early stance, mid- to late-stance) and swing. The TVA time series was reviewed to 
identify instances when the TVA was zero, or crossed over from inclined to reclined [Owen, 
2010] and vice versa. These peak knee flexion values and TVA cross-over times are summarized 
in Figures 4.2 and 4.3, respectively.  
 The mean peak knee flexion at these various periods were normally distributed. 
Statistical comparison of these measures across AFO conditions using the General Linear Model 
(GLM) indicated that peak knee flexion differed significantly between AFO conditions for all 
periods. During IC, peak knee flexion for the DRAFO condition differed significantly from both 
the no AFO and free AFO conditions. During early stance or LR, peak flexion in the DRAFO 
condition differed significantly from all other AFO conditions. During mid- to late-stance, the 
minimum knee flexion with the DRAFO differed significantly from the free AFO condition only. 
Finally, during swing, no statistically significant differences in peak knee flexion were observed 
with the DRAFO; the only statistically significant difference in peak knee flexion was between 
the no AFO and free AFO conditions (see Appendix A).   
 The TVA cross-over times were also normally distributed. Further statistical comparison 
using the GLM indicated significant differences in TVA cross-over timings during both stance 
and swing. Post hoc testing (Tukey) detected differences between the DRAFO and the no AFO, 
free AFO, and locked AFO conditions for both stance and swing phase (p < 0.05, Appendix A). 
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Figure 4.1: Sagittal plane knee angle (solid black) and TVA (dashed black), mean ±1 s.d., as a function of gait cycle for a 
representative subject (#3) for each of the AFO test conditions.  The vertical lines represent contralateral toe off (cTO), contralateral 
heel strike (cHS) and ipsilateral toe off (iTO). TVA cross-over times are marked with “X”. 
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Figure 4.2: Mean peak knee angles across all subjects and gait cycles during IC, early stance (0-
30% GC), late-stance (30-70% gait cycle), and swing.   
* indicates significance at p<0.05 level 
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Figure 4.3: Mean TVA cross-over times during stance (top) and swing (bottom). 
* indicates significance at p<0.05 level 
 
 
 
4.2.2 Ankle Angle and Shank to Vertical Angle (SVA) 
Representative mean sagittal plane ankle angle and SVA time series waveforms are 
presented in Figure 4.4. The AFOs reduced the ankle ROM, limiting ankle plantarflexion. Peak 
dorsiflexion was observed at mid–stance, at contralateral heel contact. The DRAFO condition 
resulted in delays of both the stance and swing SVA cross-over times. 
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To facilitate kinematic comparison between AFO conditions, the sagittal plane ankle 
angle time series were reviewed to determine peak values during early stance (first rocker), mid- 
to terminal-stance (second rocker), late stance (third rocker), and swing. The SVA time series 
were reviewed to identify the times at which cross-over (e.g., transition from positive to negative 
values and vice versa) occurred. These measures are summarized in Figures 4.5 and 4.6 across 
all subjects and gait cycles for all AFO conditions. 
 With the exception of swing, the mean peak ankle measures during stance were normally 
distributed. Statistical comparison of these measures across AFO conditions using GLM 
indicated that statistically significant differences were observed between AFO conditions (p < 
0.05). Subsequent post hoc (Tukey) testing indicated that peak plantarflexion during early stance 
differed between the DRAFO and no AFO and between the locked and free AFO conditions. 
Peak plantarflexion during early stance with the DRAFO differed from both the locked and free 
AFO conditions; the no AFO condition differed from the free and locked AFO conditions. Peak 
dorsiflexion during MSt for the no AFO condition differed from the DRAFO condition; peak 
dorsiflexion during MSt with the DRAFO condition differed from the free and locked AFO 
conditions. Peak plantarflexion during late-stance with the no AFO condition differed from the 
DRAFO and all AFO conditions, as all AFOs minimized ankle plantarflexion to assist with foot 
clearance. The peak dorsiflexion during swing (non-normally distributed data; tested with 
Friedman’s test and Wilcoxon Sign Rank post hoc testing) indicated statistically significant 
differences between the DRAFO and no AFO conditions, as well as between the DRAFO and the 
locked and free AFO conditions (Appendix B). 
 Stance and swing phase SVA cross-over times were both normally distributed. Statistical 
comparison of these measures using GLM indicated statistical significance only for SVA cross-
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over time during swing (p < 0.05). Post hoc testing (Tukey) indicated that the SVA cross-over 
time with the DRAFO differed from that with no AFO and the free AFO (Appendix B).  
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Figure 4.4: Mean sagittal plane ankle angle (solid black) and SVA (dashed black), mean ±1 s.d. (+ ankle angle: dorsiflexion) across all 
gait cycles for a representative subject (#3) for each of the AFO conditions. The vertical lines represent contralateral toe off (cTO), 
contralateral heel strike (cHS) and ipsilateral toe off (iTO) events. SVA cross-over times are marked with “x”.
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Figure 4.5: Mean peak plantarflexion during early stance, peak dorsiflexion during MSt, peak 
plantarflexion during late stance/early swing, and peak dorsiflexion during swing. 
* significant difference at p<0.05 level 
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Figure 4.6: Mean SVA cross-over times during stance (top) and swing (bottom). 
* indicates significance at p<0.05 level 
 
  
4.2.3 Foot Progression Angle (FPA) 
 To measure the effect of AFOs on FPA, the minimum and maximum values during 
stance were calculated and averaged across subjects for each AFO condition (Figure 4.7).  As the 
mean minimum foot progression angles were non-normally distributed, Friedman’s test was 
performed to identify significant differences between AFO conditions; subsequent Wilcoxon 
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Sign Rank tests were then conducted. Significant differences in the minimum foot progression 
angle were observed between the no AFO and DRAFO conditions. Similar statistical analysis of 
the mean maximum foot progression angle (normally distributed, investigated using a GLM) did 
not indicate significant differences between AFO conditions (Appendix C). 
 
 
Figure 4.7: Mean minimum (black) and maximum (gray) foot progression angle during stance 
across subjects for each AFO condition. 
* indicates significance at p<0.05 level 
 
 
4.2.4 Step Width 
 The step width at heel strike was averaged for all gait cycles and subjects for each AFO 
conditions (Figure 4.8).  This measure might provide insight into AFO stability during stance. 
Step width data were normally distributed significant differences between AFO conditions were 
investigated using a GLM to determine significance among conditions. No significant 
differences between AFO conditions were observed (Appendix D).  
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Figure 4.8: Mean step width at heel strike across subjects for each AFO condition. 
* indicates significance at p<0.05 level 
 
 
4.3. EMG Activity 
 A second objective of this study was to compare the EMG activity duration of the 
dorsiflexors (anterior tibialis) and plantarflexors (gastrocnemeus) for the four AFO conditions to 
test the hypothesis that EMG activity during stance will not differ between the no AFO and 
DRAFO conditions but will between the DRAFO and free/locked AFO conditions.  
The normalized linear envelope of the respective surface EMGs was contrasted for the 
four AFO conditions (dorsiflexors: Figure 4.9, plantarflexors: Figure 4.10); the corresponding 
activation periods (e.g. period for which the normalized EMG exceeded the 20% activation 
threshold) are also noted. The activity durations during stance and swing across all subjects and 
gait cycles are contrasted between AFO conditions in Figure 4.11.   
The dorsflexion activity duration during swing and plantarflexor activity duration during 
stance were normally distributed; these EMG data were contrasted between AFO conditions 
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using the GLM with subsequent Tukey’s post hoc testing to investigate potential significant 
differences between AFO conditions. Dorsiflexor activity duration during stance and 
plantarflexion activity during swing were non-normally distributed; Friedman’s test and 
Wilcoxon Sign Rank post hoc tests were conducted to investigate potential differences in these 
muscle activity durations between AFO conditions.  
These post-hoc analyses indicated that dorsiflexor activity duration during swing differed 
significantly between the no AFO and the DRAFO conditions; dorsiflexor activity duration 
during swing with no AFO also differed from the free and locked AFO conditions. No significant 
differences in dorsiflexion activity duration were observed during stance.  Plantarflexor activity 
duration during swing also differed significantly between the no AFO and locked AFO 
condition; no differences in plantarflexor activity duration during stance were observed 
(Appendix E).  
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Figure 4.9: Representative normalized linear envelope of dorsiflexor EMG (mean ±1 s.d.) for 
subject 5 for all AFO conditions. Filled black horizontal bars represent “ON” or activation 
periods during which activity exceeded the 0.2 threshold. The vertical black line indicates TO, 
thereby differentiating stance from swing.  
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Figure 4.10: Normalized linear enveloped plantarflexor EMG (mean ±1 s.d.) for subject 5 for all 
AFO conditions. Black bars represent “ON” or activation period. The vertical black line 
indicates TO, thereby differentiating stance from swing. 
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Figure 4.11: Dorsiflexor (top) and /plantarflexor (bottom) activation periods during stance (left) 
and swing (right) across subjects for all gait cycles. 
* significant difference at p<0.05 level 
 
 
4.4 Medial/Lateral Motion of the Center of Pressure (COP)  
 The final research objective was to contrast the medial-lateral motion of the COP for the 
four different AFO conditions (see Figure 4.12).  The related research hypothesis was that the 
mediolateral motion of the COP with the DRAFO would approximate the no AFO condition and 
would differ from that with the free/locked AFO conditions.  
The peak medial and lateral motion of the COP relative to the long-axis of the foot are 
represented in Figures 4.13 and 4.14 for the stance sub-phases, LR, MSt, TSt, and PSw.  This 
COP movement during the various sub-phases was then contrasted between AFO conditions, as 
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shown in Figure 4.14.  As the peak medial and lateral motion of the COP during the various 
stance sub-phases were normally distributed, these measures were contrasted using the GLM and 
with subsequent Tukey’s post hoc testing to identify potential significant differences between 
AFO conditions.  
During LR, TSt and PSw, the peak medial motion of the COP for the DRAFO condition 
differed from the no AFO condition. During MSt, the COP motion with the DRAFO differed 
significantly from both the no AFO and free AFO conditions. The maximum medial motion of 
the COP during PSw also differed between the DRAFO and free AFO conditions. 
Peak lateral motion of the COP relative to the long axis of the foot differed significantly 
between the DRAFO, no AFO, and free AFO conditions during LR. During MSt and TSt, the 
peak lateral motion of the COP for the DRAFO condition significantly differed from the no AFO 
condition.  Finally, during TSt, the peak lateral motion of the COP differed between the DRAFO 
and free and locked AFO conditions. No significant differences in peak lateral motion of the 
COP were observed between AFO conditions during PSw (Appendix F). 
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Figure 4.12: Representative mean (blue) and standard deviation (black dashed) motion of the 
COP in the transverse plane from HS (o) to TO (x) for multiple gait cycles for each AFO 
condition (subject 3).  
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Figure 4.13: Mean mediolateral motion of the COP across all subjects during the 
various stance sub-phases for each AFO condition (blue = no AFO, green = 
DRAFO, red = free, purple = locked AFO). For reference, the COP progression 
from able-bodied subjects is also shown (black circles) [10]. 
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Figure 4.14: Mean motion of the COP relative to the heel-to-toe long axis of the foot during the 
LR, MSt, TSt, and PSw sub-phases of stance. As all COPs were lateral to the long axis of the 
foot, these values represent the minimum lateral motion (left) and maximum lateral motion 
(right) of the COP. 
Significant differences (p<0.05) between AFO conditions are noted with an *. 
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4.5 POWER ANALYSIS 
 A priori power analyses were performed to determine the sample size necessary for the 
study at pre-defined effect sizes (Table 4.2). Small (0.3), medium (0.5), and large (0.8) effect 
sizes were investigated. No data regarding ankle angle, EMG activity or COP motion were 
reported in AFO investigations in the literature; current literature were therefore reviewed to 
estimate sample size based on reported sagittal plane knee angle [29]. Sample sizes of 5 to 71 
subjects were projected for large to small effect sizes, respectively - motivating the initial sample 
size of 10 subjects included in this study. The respective parameter effect size and power are 
summarized in Table 4.3. 
 
 
Table 4.2: A prior power analysis as a function of effect size and the corresponding 
sample size estimates. 
 Effect size # subjects 
Small 0.3 71 
Medium 0.5 27 
Large 0.8 12 
sagittal 
plane knee 
angle [28] 
1.6 5 
Early knee 
flexion 
[this study]  
1.44 7 
 
 
Effect sizes for knee and ankle kinematics, SVA, and dorsiflexion activity duration were 
large (d > 0.8) and had power greater than 0.7. The effect sizes for the plantar flexion muscle 
activity duration and COP motion were medium (d > 0.5) and resulted in powers greater than 0.3 
(small) and >0.5 (medium), respectively. A small effect size (d > 0.3) was observed for the TVA 
cross-over time during stance, with small (~0.2) power. The full power analyses are summarized 
in Appendix G. 
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Table 4.3: Post hoc power analysis of select study parameters. 
Measure Effect size Power 
Knee flexion --- 
LR 
0.92 0.74 
Ankle 
dorsiflexion --- 
stance 
1.44 0.98 
TVA cross-over 
time --- stance 
0.41 0.21 
SVA cross-over 
time --- stance 
0.99 0.79 
Peak FPA 0.47 0.39 
Step width 0.39 0.30 
Dorsi activity 
duration --- LR 
0.0067 0.05 
Plantar activity 
duration --- stance 
0.28 0.13 
Peak lateral COP 
during LR 
0.77 0.59 
 
 
4.6 SUMMARY 
 Kinematic, EMG, and kinetic data were statistically analyzed in relation to the study 
hypotheses. Statistically significant kinematic differences were detected between the DRAFO 
and no AFO conditions. Peak ankle dorsiflexion during both stance and swing phase n, as well as 
peak plantarflexion during PSw, differed between these conditions. Peak knee flexion throughout 
the stance differed significantly between the DRAFO and no AFO conditions. In addition, the 
TVA cross-over time during both stance and swing differed between the DRAFO and no AFO 
conditions; only the SVA cross-over time during swing differed between AFO conditions. The 
minimum FPA also differed significantly between the DRAFO and no AFO condition. Swing 
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phase dorsiflexion activity duration differed significantly between the DRAFO and no AFO 
condition; no differences in dorsiflexion or plantarflexion activity duration during stance were 
observed between the DRAFO and no AFO. 
 Kinematic parameters that differed between the DRAFO and locked or free AFO 
conditions included: ankle angle at IC, early stance dorsiflexion, swing phase dorsiflexion, and 
peak knee flexion during stance. The TVA cross-over time for both stance and swing also 
differed between the DRAFO and AFO conditions, as did the SVA cross-over time during swing 
(DRAFO and free AFO only). No significant differences in either dorsi or plantar flexion activity 
duration were found between the DRAFO and AFO conditions. The COP progression differed 
significantly between the DRAFO and free AFO conditions from LR through PSw. 
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Chapter 5: DISCUSSION 
 AFO prescription objectives include: 1) re-establish an appropriate base of support, 2) 
control rate, excursion, and direction of segment movement, 3) improve energy efficiency, and 
4) aid foot positioning for clearance and weight acceptance [2]. As such, use of AFOs may assist 
patients by returning their gait to normal, or near normal, kinematic patterns. This may reduce 
incidence of compensatory gait mechanisms, thereby decreasing pain and facilitating safer, more 
efficient, and more comfortable gait for prolonged durations.  
Due to the soft heel, plantar flexed alignment and rigid frame, the specific research 
hypotheses investigated in this study were: 1) DRAFO-assisted gait parameters (e.g. ankle 
plantarflexion during early stance, swing phase SVA and TVA cross-over times, step width and 
LR COP progression) will approximate that of the no AFO condition and 2) DRAFO-assisted 
gait parameters (e.g. ankle and knee kinematics, stance phase SVA and TVA cross-over times, , 
step width, stance phase dorsiflexion activity duration, and COP progression during LR) will 
differ from that for articulating and rigid AFOs. To test these hypotheses, kinematic, EMG and 
kinetic measures were contrasted for able-bodied subjects wearing various AFOs during level 
treadmill walking. 
This chapter will discuss the resultant knee, ankle and foot kinematics, shank and thigh 
segment angles, dorsiflexor muscle activity duration, and COP progression data, the respective 
research hypotheses (Tables 1.1 and 5.1), and corresponding data from prior investigations 
reported in the literature. 
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Table 5.1: Summary of gait parameter results in terms of the research hypotheses.  
(+):hypothesis supported, (-):hypothesis not supported, (~):hypothesis testing 
inconclusive, (--------):measures not relevant to research hypothesis. 
 
Metric Hypothesis 1: 
DRAFO ≈ no AFO 
Hypothesis 2: 
DRAFO ≠ locked AFO 
DRAFO ≠ free AFO 
Ankle Kinematics 
- LR plantarflexion 
- MSt dorsiflexion 
- TSt-PSw plantarflexion 
- Swing dorsiflexion 
 
+ 
---------------------------- 
---------------------------- 
---------------------------- 
 
+ 
+ 
- 
+ 
Knee Kinematics 
- IC/LR flexion 
- MSt minimum flexion 
- TSt-PSw flexion 
- Swing flexion 
 
---------------------------- 
---------------------------- 
---------------------------- 
---------------------------- 
 
+ 
+ 
+ 
- 
Step width + - 
SVA cross-over time 
- Stance 
- Swing 
 
---------------------------- 
- 
 
- 
---------------------------- 
TVA cross-over time 
- Stance 
- Swing 
 
---------------------------- 
- 
 
+ 
---------------------------- 
Dorsiflexion activity duration 
- Stance (LR) 
-  
 
+ 
---------------------------- 
 
- 
---------------------------- 
COP progression (LR) - ~ 
 
 
5.1 KINEMATICS 
 AFOs are commonly prescribed to treat ankle and subtalar joint instability by providing 
rigid support of the foot and ankle. This support often decreases kinematic pathologies during 
gait and may reduce joint pain and muscle spasticity. The DRAFO incorporates a heel cut out 
and flexible inner layer to enhance proprioception to assist in detecting heel strike, and may 
decrease potential gait pathologies introduced by more traditional rigid AFOs.  However, the 
82 
 
rigid frame supporting the ankle and subtalar joints, as well as the plantarflexed alignment of the 
DRAFO, may contribute to additional gait pathologies or compensatory mechanisms. 
 
5.1.1 Joint Angles 
5.1.1.1 Knee Kinematics 
 During IC, greater knee flexion was observed with the DRAFO condition (8.38±3.43°) 
than for all other conditions (No AFO: 4.71±4.47, free AFO: 5.48±4.21, locked AFO: 
4.89±4.78°). Throughout stance phase, knee flexion in the DRAFO differed significantly from 
that for the No AFO, locked, and free AFO conditions.  For example, during early stance, greater 
knee flexion was observed with the DRAFO (20.60±4.47°) vs No AFO (15.89±5.57°), locked 
AFO (16.49±5.07), and free AFO (16.64±4.36) conditions.  In contrast, during late stance, the 
knee was less flexed with the DRAFO (5.00±5.60°) vs No AFO (10.51±5.21), free AFO 
(10.89±6.05), and locked AFO (8.20±6.63°) conditions. These differences in knee flexion during 
stance were associated with medium power (>0.7). No significant differences in knee flexion 
were observed between the DRAFO and other AFO conditions during swing, although modest 
power was associated with these measures (approximately 0.05).  
During able-bodied gait [10], the knee is slightly flexed during IC. The knee flexes 
further during LR to provide shock absorption. As the shank transitions from a reclined to an 
inclined position during the second rocker of MSt, the knee begins to extend as the body COM 
advances over the foot. The knee remains extended throughout TSt, flexing during PSw in 
preparation for swing. During swing, the knee flexes through mid-swing to provide foot 
clearance; the knee then extends to prepare the limb for IC and weight acceptance.  
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For the DRAFO condition, the increased knee flexion observed during IC and MSt may 
be attributed to the presence of the external heel wedge that increased the effective shank length; 
the observed increased knee flexion during early stance therefore may simply have been 
introduced to maintain the overall limb length and minimize vertical motion of the body COM. 
The increased knee flexion with the DRAFO during early stance, together with the reduced knee 
flexion during PSw, contributed to greater knee ROM with the DRAFO during stance phase.  
Other studies observed increased maximum knee flexion during stance with AFO use 
[30-32]. Increased heel height and plantarflexed alignment via external heel wedges was found to 
increase knee flexion and internal knee extensor moments during MSt for young healthy subjects 
wearing rigid AFOs [30]; these results are consistent with that observed with the plantarflexed 
DRAFO in the current study. Knee flexion at IC was also observed to increase for individuals 
with cerebral palsy (CP) wearing rigid AFOs [29]. Desloovere observed increased knee flexion 
during stance with rigid AFOs; although these AFOs were aligned in a neutral, not plantarflexed, 
orientation, these results were consistent with that observed in the current study for the 
conventional AFOs [28].  
Clinically, decreased knee flexion during stance may be observed for patient populations 
with knee joint pain during load bearing (e.g. knee osteoarthritis) [33]. For individuals with genu 
recurvatum, increased knee flexion is encouraged during early stance via AFO use to prevent 
further joint deformity; prior studies have shown that increased knee flexion during early stance 
reduces hyperextension of the knee [34]. The increased knee flexion with the DRAFO (which 
increased ankle plantarflexion via alignment and the inclusion of the external heel wedges) 
during early stance may therefore assist both of these patient populations, although the primary 
benefit may be due to the external heel wedge, not the DRAFO itself.  A contraindication for the 
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DRAFO and/or for use of external heel wedges, includes individuals with weak quadriceps 
muscles.  Increased knee flexion during early stance requires enhanced quadriceps activity to 
stabilize the increased internal knee flexion moment and prevent knee buckling.  As such, 
increased knee flexion during early stance, may lead to increased energy costs due to the 
requisite increased quadriceps activity [20]. 
AFO designs that stabilize the ankle in a neutral position via a rigid (or semi-rigid) 
structure assist with foot and toe clearance during swing phase. As the DRAFO was aligned in a 
plantarflexed position, increased knee flexion was expected as a compensatory mechanism. As 
such, although increased knee flexion during swing is unnecessary for conventional AFOs, it was 
expected in the DRAFO condition to compensate for the plantarflexed alignment. In this study, 
peak knee flexion during swing did not differ from the no AFO and the DRAFO and locked AFO 
conditions.  However, greater knee flexion was observed with the free AFO condition (65.78° vs. 
63.68°) during swing, as the plantarflexion stop of the free AFO did not fully constrain ankle 
plantarflexion due to gravity.  
Due to both design and alignment differences between the DRAFO and traditional AFOs 
(e.g., soft heel, external heel wedge and plantarflexed alignment), the DRAFO was expected to 
increase knee flexion during both stance and swing relative to the conventional AFOs 
(Hypothesis 2). Greater knee flexion was observed with the DRAFO during early stance, as was 
reduced knee flexion during late stance relative to these conventional AFOs, supporting the 
second hypothesis during stance. However, no differences in knee angle were observed between 
the DRAFO and the free and locked AFO conditions during swing. As such, the second 
hypothesis was only supported for knee flexion during stance, not for swing. 
 
85 
 
5.1.1.2 Ankle Kinematics 
During early stance, greater plantarflexion was observed in the DRAFO condition (-
1.08±3.47°) relative to the slightly dorsiflexed ankle position observed with both the free 
(2.61±3.31°) and locked (3.75±2.78°) AFO conditions; ankle plantarflexion during early stance 
however, did not differ between the DRAFO and no AFO conditions. During MSt, dorsiflexion 
was reduced in the DRAFO (7.36±4.41°) compared to the no AFO condition (12.97±2.94°); 
ankle dorsiflexion was also reduced with the DRAFO (7.36±4.41°) relative to the free 
(16.82±3.98°) and locked (14.27±3.79°) AFO conditions. During late stance, plantarflexion was 
reduced for the DRAFO (-0.21±2.02°) compared to the no AFO condition (-14.32±6.24°). 
Finally, during swing phase, peak dorsiflexion was reduced for the DRAFO (4.11±4.24°) 
compared to the no AFO (7.67±5.26°) condition, as well as for the free (7.84±3.84°) and locked 
AFO (8.00±3.44°) conditions.   
For an able-bodied subject [10], greater ankle ROM during ambulation is expected than 
with any AFO. Ankle motion during able-bodied gait can be described by a neutral ankle 
position at IC, with gradual plantarflexion and eccentric dorsiflexor activity to prevent foot slap 
during the first rocker. During MSt through TSt (second rocker), the ankle dorsiflexes as the tibia 
rolls over the ankle. During PSw, the ankle plantarflexes, providing active push-off in 
preparation for swing.  Finally, during swing, the ankle dorsiflexes to provide foot and toe 
clearance; this dorsiflexion is then reduced to establish a neutral ankle orientation to prepare for 
IC. 
The effect of AFOs on gait is dependent on 1) dorsi- and/or plantarflexion constraints 
(e.g., articulated and free, articulated with a plantarflexion stop, or solid/locked) and 2) ankle 
orientation in the AFO. A solid, non-articulating AFO prohibits both dorsi- and plantarflexion 
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and aligns the ankle in a neutral position; ankle motion during both stance and swing is therefore 
expected to be minimal (reduced plantarflexion during early stance, reduced dorsiflexion during 
MSt-TSt, reduced plantarflexion during PSw, and reduced dorsiflexion during swing). In 
contrast, an articulated, free AFO theoretically permits some dorsiflexion as well as some 
plantarflexion.  However, articulated, free AFOs often incorporate a plantarflexion stop, 
minimizing plantarflexion due to gravity during swing. 
The traditional AFOs investigated in this study included both a locked AFO and an 
articulated AFO with a plantarflexion stop.  Subject ambulation in these AFOs resulted in the 
expected ankle kinematics described above. During early stance, these AFO conditions resulted 
in slight dorsiflexion, rather than plantarflexion, due to the plantarflexion constraints of these 
designs.  These ankle kinematics during early stance are consistent with prior literature involving 
both healthy and hemiplegic individuals wearing an articulated polypropylene AFO [35], as well 
as hemiplegic individuals wearing a dynamic, articulated AFO [36]. PSw plantarflexion was also 
reduced relative to the no AFO condition due to the constrained ankle motion of the locked AFO 
and the plantarflexion stop of the free AFO, again consistent with prior gait analysis of young, 
diplegic subjects wearing dorsiflexed, polypropylene AFOs [37]. Contrary to expectations, ankle 
kinematics during MSt with the conventional AFOs demonstrated greater dorsiflexion than with 
no AFO condition. The locked AFO resulted in a mere 1° increase in dorsiflexion, which would 
likely be clinically insignificant; the increased dorsiflexion during MSt with the free AFO may 
have been attributed to AFO alignment and the unconstrained ankle movement. Increased 
dorsiflexion during MSt has also been observed for diplegic and hemiplegic individuals 
ambulating in solid and free AFOs, as well as with a posterior leaf spring (PLS) AFO, compared 
to control subjects ambulating without an AFO [38]. 
87 
 
The DRAFO design, despite the flexible inner liner, is a solid, non-articulating AFO 
aligned in 3° plantarflexion with additional shank inclination due to the incorporation of external 
heel wedges. Therefore, the DRAFO was expected to increase ankle plantarflexion during early 
stance (IC-LR), reduce dorsiflexion during MSt and reduce active plantarflexion during PSw 
relative to the no AFO condition. The observed DRAFO results were largely consistent with 
these expectations. During MSt, while ambulating with the DRAFO, more plantarflexion was 
observed relative to the traditional AFO conditions. However, the DRAFO resulted in reduced 
plantarflexion relative to the no AFO condition during TSt, perhaps due to the rigid frame 
restricting ankle motion. 
Peak dorsiflexion during swing was reduced for all AFO conditions compared to the no 
AFO condition, as the AFOs structure does not permit the same level of ankle movement. The 
DRAFO, due to its plantarflexed alignment and rigid outer shell, was even less dorsiflexed 
during swing than both the free and locked AFO conditions. The lack of dorsiflexion during 
swing phase can lead to compensatory adjustments in knee/hip kinematics to provide necessary 
toe clearance. 
The findings in this study indicated that ambulation in the DRAFO resulted in greater 
plantarflexion throughout LR-MSt and swing phase than in the conventional AFOs, but that 
ankle angle during early stance (IC-LR) was comparable to that without an AFO. Clinically 
prescribed AFOs are aligned in a nominal position that provides a pain free range of motion 
(ROM), yet provides stability during stance and/or acts to decrease ankle/subtalar joint 
deformity.  The plantarflexed alignment of the DRAFO would be contraindicated for patients 
with pain during ankle plantarflexion.  
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A second prescription criterion for AFOs is to prevent plantarflexion during swing to 
reduce risk of tripping. The DRAFO is aligned in a more plantarflexed position than 
conventional AFOs, which may contribute to compensatory mechanisms (i.e., increased knee 
and/or hip flexion) to lift the lower limb during swing to provide toe clearance. However, for the 
conventional AFOs in this study, ankle dorsiflexion during swing did not differ from the no AFO 
condition, demonstrating that these traditional AFOs provide adequate foot clearance during 
swing phase. For the DRAFO condition, the ankle was actually plantarflexed during swing, 
introducing a possible tripping risk.  Individuals with unimpaired knee and hip flexors might 
therefore increase knee/hip flexion to compensate and provide the extra toe clearance needed 
during swing. For individuals with weak knee/hip musculature, the DRAFO alignment and/or 
incorporation of external heel wedges may need to be modified to reduce tripping or toe drag. 
Ankle kinematics in the DRAFO were not expected to differ from the no AFO condition 
during early stance. No significant differences in ankle plantarflexion during early stance were 
observed between the DRAFO and no AFO conditions, supporting Hypothesis 1. 
The plantarflexed alignment of the DRAFO condition was expected to differentiate ankle 
kinematics from that of the conventional AFOs during both stance and swing (Hypothesis 2). 
During treadmill ambulation in the DRAFO versus the conventional AFOs, increased 
plantarflexion was observed during early stance and reduced dorsiflexion was observed during 
MSt, supporting the second hypothesis. The low statistical power was associated with ankle 
kinematics during early stance, however, may minimize key differences; an expanded subject 
population may be necessary to ensure identification of significant changes between the AFO 
designs to effectively investigate the second hypothesis.  In contrast, ankle plantarflexion during 
MSt-PSw did not differ between the DRAFO and conventional AFO conditions, failing to 
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support the second hypothesis during these latter sub-phases; strong power (0.98) was associated 
with these measures. Finally, the plantarflexed alignment of the DRAFO was expected to 
increase plantarflexion during swing relative to the conventional AFOs, a result that was 
confirmed by this study with medium power (0.55).  In summary, the ankle kinematics, with the 
exception of MSt-PSw, differed between the DRAFO and conventional AFOs, confirming 
Hypothesis 2 (see Table 5.1). 
 
5.1.2 Segment Angles 
 The TVA cross-over time was delayed with the DRAFO relative to all other conditions 
during both stance and swing (DRAFO: stance 30.16±4.49%, swing 67.08±2.68%; no AFO: 
stance 25.92±4.07%, swing 66.19±2.40%; free AFO: stance 26.29±4.51%, swing 65.25±2.84%; 
and locked AFO: stance 25.77±4.41%, swing 65.83±2.71% gait cycle).  In addition to the 
comparison of TVA cross-over time as a percentage of gait cycle, these TVA cross-over times 
were also contrast in actual time (DRAFO: stance 0.36±0.06 sec, swing 0.79±0.07 sec; no AFO: 
stance 0.30±0.06, swing 0.76±0.07 sec; free AFO: 0.30±0.06 sec, swing 0.75±0.08 sec; locked 
AFO: 0.30±0.05 sec, swing 0.76±0.08 sec).  In actual time, the TVA cross-over time was 
significantly delayed during stance and swing relative to the other AFO conditions. 
 SVA cross-over times did not differ significantly different between the four AFO 
conditions during stance. During swing, however, the SVA cross-over time was significantly 
delayed with the DRAFO (89.42±2.35% gait cycle, 1.05±0.09 sec) compared to the no AFO 
(88.08±1.00% gait cycle, 1.01±0.08 sec) and free AFO (88.07±1.41% gait cycle, 1.02±0.09 sec) 
conditions. These SVA cross-over times during swing were also reviewed in actual time; as for 
SVA cross-over time in percent gait cycle, the SVA cross-over time with the DRAFO condition 
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was significantly delayed during swing phase compared to the free and locked AFO conditions. 
These delays, however, while statistically significant are likely not clinically significant. 
Clinical AFO alignment guidelines dictate that the shank be vertical at MSt.  A common 
misconception is that the shank and thigh are vertical at the same time during gait [23]. However, 
observations from both Owen and the current study indicate that the shank rotates to a vertical 
position prior to the thigh, e.g. SVA cross-over time precedes TVA cross-over time. For the AFO 
conditions in the current study, the shank and thigh were never concurrently vertical (e.g. 
SVA=0° and TVA=0° at the same time). The SVA cross-over time during stance was observed 
at 10.5 – 11.1% cycle (late LR to early MSt); the TVA cross-over time occurred at 25.8-30.2% 
gait cycle (late MSt).  
 
5.1.2.1 TVA 
The TVA cross-over time during stance was delayed with the DRAFO relative to the no 
AFO condition. This delay is consistent with the increased knee flexion and ankle plantarflexion 
observed during early/MSt with the DRAFO. The plantarflexed DRAFO alignment, together 
with the external heel wedges, results in an inclined shank during foot flat, contributing to a more 
reclined thigh and flexed knee throughout stance phase (Figure 4.1). The reclined thigh requires 
additional time to transition to an inclined position, thereby delaying the stance TVA cross-over 
time.  
Few studies have investigated thigh and shank segment kinematics via TVA and SVA 
measures. Owen demonstrated that thigh segment transitioning from a reclined to inclined 
position assists forward progression of the trunk [Owen, 2010]. Accelerated stance TVA cross-
over times therefore reflect decreased SLS duration and potential instability during MSt.  
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The delayed stance TVA cross-over time with the plantarflexed DRAFO may perhaps be 
attributed to a more reclined thigh and inclined shank from IC through stance TVA cross-over 
(Figure 4.1). The delayed stance TVA cross-over time was approximately 5% gait cycle relative 
to both the no AFO and conventional AFO conditions.  The inclined shank and reclined thigh 
move the knee center of rotation posteriorly, resulting in a more stable internal knee extension 
moment during early stance and potentially prolonged stance and SLS duration. However, this 
delay is likely not clinically significant as it is less than 2% gait cycle or approximately 60 msec. 
A more inclined thigh may correspond to increased hip extension during late stance, requiring 
increased hip flexor activity and energy costs to lift the limb into swing. 
The heel wedges and plantarflexed alignment of DRAFO was only expected to affect 
SVA cross-over time and forward progression during stance. As such, the DRAFO was not 
expected to alter TVA cross-over time during swing relative to the no AFO condition 
(Hypothesis 1). However, these DRAFO design were expected to affect the TVA cross-over time 
during stance between the DRAFO and the conventional AFOs (Hypothesis 2). Significant 
differences in TVA cross-over time during swing were observed between the DRAFO and no 
AFO condition, failing to support Hypothesis 1. Significant differences in TVA cross-over time 
during stance were found between the DRAFO and conventional AFOs, supporting Hypothesis 
2. These modest differences of approximately 1-5% gait cycle (less than 60 msec) were 
associated with low power (see Appendix G), and should therefore be confirmed with future 
testing of both an expanded population of able-bodied subjects and a clinical population that are 
candidate for AFOs. 
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5.1.2.2 SVA 
Analysis of segment, rather than joint, angles may assist determination of AFO alignment 
and understanding of the effects of AFOs on gait [13, 23, 30]. MSt has been identified as a 
challenging phase of the gait cycle as it reflects single limb support. The shank position during 
MSt: 1) contributes to knee stability affecting the position of  the knee center of rotation relative 
to the weight-line and GRF, 2) affects forward progression of the thigh, pelvis, and trunk (trunk 
glide: relatively stationary shank during MSt with forward momentum advancing the thigh, 
pelvis, and trunk, and extending the knee, [39]), 3) influences thigh, pelvis, trunk, and head 
kinematics, 4) controls GRF alignment and alters internal joint moments at the knee and hip, and 
5) may influence energy expenditure [23], [37].  
The SVA is dependent on heel height [30]; increased heel height (e.g. due to external 
shoe wedges) results in an inclined shank at foot flat. Increased heel height has been observed to 
increase knee flexion and the internal knee extension moment during MSt for healthy subjects 
wearing rigid AFOs [30]. As alignment of the SVA affects knee kinematics, SVA can be used as 
a potential clinical measure to align AFOs to alter joint kinematics and stability during stance. 
For example, a SVA of 14° inclination imposed via heel wedges reduced knee hyperextension 
during MSt for a hemiplegic patient wearing a rigid AFO [13]. 
The plantarflexed alignment and external heel lifts of the DRAFO were expected to affect 
SVA cross-over timing relative to the no AFO condition during stance, providing an inclined 
shank to assist limb advancement through MSt. However, the stance SVA cross-over time did 
not differ from the no AFO condition, while still providing enhanced knee flexion.  Despite the 
10° inclination at MSt, the SVA cross-over time during stance with the DRAFO was not 
advanced relative to the free and locked AFO conditions, indicating that the DRAFO did not 
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accelerate limb advancement. This unexpected behavior may be due to treadmill, rather than 
overground, ambulation and minor differences in self-selected walking speed for each AFO 
condition. 
The plantarflexed alignment and external heel wedges of the DRAFO were also expected 
to affect the swing SVA cross-over time.  However, no differences in SVA cross-over time were 
observed between AFO conditions. The plantarflexed AFO alignment and/or incorporation of 
heel wedges therefore did not affect swing phase shank kinematics.  
Clinically, the SVA cross-over time may be used to understand knee and hip kinematics. 
Delays in SVA cross-over time during both stance and swing, in combination with knee and hip 
kinematics, may provide a more holistic view of forward progression of the body COM and 
swing limb advancement to assist assessment of AFO alignment. 
The DRAFO was not expected to alter SVA cross-over time during swing compared to 
the no AFO condition.  The stance SVA cross-over time differed between the DRAFO and no 
AFO conditions, failing to support the first hypothesis with a high power (0.79). 
The plantarflexed alignment and external heel wedges of the DRAFO were expected to 
affect SVA cross-over time during stance of the DRAFO from the neutrally-aligned conventional 
AFO conditions (Hypothesis 2). However, despite the high power (0.79) associated with this 
measure, the stance SVA cross-over time did not differ significantly between the DRAFO and 
conventional AFO conditions. This lack of support for Hypothesis 2 may be attributed to the 
healthy subject population; individuals were able to push through the stance-to-swing transition, 
and fight the AFO.  
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5.1.3 FPA 
 FPA characterizes foot placement in the coronal plane, evaluating with the foot is 
internally (“toe in”) or externally (“toe out”) rotated. FPA is linked to the shank, which may then 
impact knee and hip biomechanics. AFO alignment may impact foot progression angle as the 
constrained foot, ankle and subtalar joints may hinder roll-over.  “Toe out” may therefore reflect 
a compensatory mechanism to facilitate roll-over and forward progress.  Analysis of foot 
progression angle therefore extends the biomechanical analysis beyond the sagittal plane. 
Statistically significant differences in minimum FPA were observed between the DRAFO 
and no AFO conditions (DRAFO: -6.02±4.18°, no AFO: -7.79±3.45°). However, no statistical 
differences in either the minimum or maximum FPA were found between the DRAFO and 
conventional AFO conditions. The lack of differences between the DRAFO and conventional 
AFOs, as well as high standard deviations may indicate that the differences are not clinically 
significant. 
 The effect of FPA on knee and hip joint kinetics has been investigated as it relates to 
injury and/or the development of OA [40, 41]. Guo et al. found that FPA with increased toe out 
reduces the second peak knee adduction moment, and therefore may be a compensatory gait 
deviation that may benefit individuals with early knee OA by [40]. Lin et al. also investigated the 
effects of FPA for healthy teenagers; increased toe in resulted in an increased knee adduction 
moment [40]. Despite differences in subject population, both studies indicate increased toe out 
reduces the knee adduction moment. 
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5.1.4 Step Width 
 AFOs are often prescribed to help stabilize the foot segment in both the sagittal and 
coronal planes, to enhance stability of the lower extremity during ambulation. Frontal plane 
stability may be inferred from step width; wider step width or a wider base of support may be 
indicative of instability.  Patients with subtalar joint instability may increase their step width as a 
compensatory mechanism; step width may then decrease with AFO use as the device may 
increase the subtalar joint stability.  Although gait analysis was only conducted for able-bodied 
subjects, analysis of step width may reflect potential instability induced by AFO use. 
 Step width was increased with AFO use relative to the no AFO condition (no AFO: 
132.96±29.34mm, DRAFO: 146.23±37.60mm, free: 141.11±33.93mm, locked: 
142.36±33.61mm), although these differences were not significant. 
 While AFOs typically increase frontal (and sagittal) plane stability and decrease step 
width for individuals with subtalar joint instability due to stroke or CP [42, 43], step width 
increased with AFO use for the able-bodied subjects who participated in this study.  The 
introduction of AFOs for this healthy population likely decreased comfort and stability, as 
reflected by the increased step width AFOs particularly with the rigid AFOs (step width with 
DRAFO > locked AFO > free AFO > no AFO). This finding is consistent with Opara who 
observed increased step width during overground ambulation in locked metal AFOs in young, 
able-bodied subjects [44]. 
 The soft heel of the DRAFO was expected to result in step widths that approximated that 
of the no AFO condition (Hypothesis 1) but differed from the conventional AFOs that 
incorporate rigid heel structures (Hypothesis 2). In fact, step width did not differ significantly 
between the DRAFO and no AFO conditions, supporting Hypothesis 1 with a modest power 
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(0.30). No significant differences in step width were observed between the DRAFO and 
conventional AFO conditions; Hypothesis 2 was therefore not supported.  
 
5.2 EMG 
 AFOs are prescribed to stabilize the ankle and subtalar joints during stance, as well as 
assist the ankle dorsiflexors (e.g. to resist plantarflexion) during swing to provide foot clearance. 
Rigid AFOs maintain the ankle in a neutral position, restricting dorsiflexion during stance and 
plantarflexion during swing. Articulating AFOs permit some dorsiflexion, and often incorporate 
a plantarflexion stop to resist gravity-induced plantarflexion during swing phase. The DRAFO 
incorporates a rigid shell, thereby approximating a rigid AFO during swing.  However, the soft 
heel permits some plantarflexion during LR.    
 No statistical differences in dorsiflexion activity duration during stance were observed 
between test conditions (no AFO: 73.15±28.28%, DRAFO: 39.82±38.69%, free AFO: 
52.97±34.29%, and locked AFO: 65.36±36.83% stance duration). However, large variability in 
dorsiflexion activity duration were observed for all AFO conditions.  Despite this variability, 
statistically significant differences in dorsiflexion activity were observed during swing. 
Dorsiflexion activity duration for all three AFO conditions was reduced relative to the no AFO 
condition during swing (no AFO: 73.15±30.19%, DRAFO: 39.82±34.71%, free AFO: 
52.97±31.40%, and locked AFO: 55.88±32.60% swing duration). Although no significant 
differences in dorsiflexion activation duration were observed between the DRAFO and 
conventional AFOs during swing, dorsiflexion activity duration with the DRAFO was 
approximately 13% less than that observed for the locked and free AFO conditions. 
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No significant differences in plantarflexion activity duration during stance were observed 
between AFO conditions (no AFO: 80.38±11.96%, DRAFO: 75.96±17.65%, free AFO: 
79.62±15.78%, and locked AFO: 85.59±14.46% stance duration). 
  
5.2.1 Dorsiflexion Activity 
 For healthy subjects, dorsiflexion activity occurs primarily during two intervals: 1) from 
IC to LR, the dorsiflexors eccentrically contract to prevent foot slap and 2) from ISw through 
TSw to assist with foot clearance. AFOs are frequently prescribed for patients with weak 
dorsiflexors (and/or spastic plantarflexors).   
Individuals with weak dorsiflexors may demonstrate foot slap during early stance or toe 
drag during swing, inducing potential instability during stance due to rapid foot flat, and 
potential tripping during swing. AFOs are often prescribed for such individuals to prevent these 
gait pathologies, and minimize fall risk due to toe drag. AFOs are therefore expected to decrease 
dorsiflexion activity, if present, during early stance and early to mid-swing. 
During stance, no significant differences in dorsiflexion activity duration were observed 
between AFO conditions. Although the AFOs held the ankle in a constant position (plantarflexed 
for DRAFO, neutral orientation for locked AFO) or prevented plantarflexion via a plantarflexion 
stop (free AFO), these healthy subjects continued to activate their dorsiflexors during LR. 
During swing, ambulation in the AFOs significantly reduced dorsiflexion EMG activity duration, 
as expected due to AFO design features that reduce gravity-induced foot drop or plantarflexion.  
 Several studies have investigated the effects of AFOs on stance phase dorsiflexor activity 
[45, 46]. Decreased dorsiflexion activity during early stance (0-15% gait cycle) was observed for 
healthy subjects wearing AFOs [38]; decreased dorsiflexor activity throughout the gait cycle was 
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observed for individuals with peripheral paresis wearing AFOs [38]. Romles et al. also noted 
decreased magnitude (36%) in dorsiflexor activity at IC for children with hemiplegic CP wearing 
a hinged AFO [39]. These results are contrary to that observed during stance in the current study, 
although the current study simply assessed dorsiflexion activity duration throughout stance (and 
swing), not activity amplitude nor activity duration during the stance sub-phases. A healthy 
population may still activate the dorsiflexors in early stance phase despite being held in a rigid 
AFO.  
 The decreased dorsiflexion activity duration observed during swing with AFO use for 
able-bodied subjects is consistent with the literature [39] (children with CP), [38] (able-bodied 
individuals and subjects with peripheral paresis), and [5] (individuals post-stroke). Many AFO 
designs (e.g., Dynamic Ankle Orthosis, locked AFO, and articulated AFO with plantarflexion 
stop) have been observed to reduce dorsiflexion activity levels during swing.  
Prior studies also investigated both the short- and long-term effects of AFO usage on 
dorsi- (and plantar-) flexor muscle activity [38]. While rigid AFOs limit the mobility of the ankle 
and subtalar joints, providing stability, these constraints may lead to muscle atrophy due to 
inactivity. One study measured the effects of AFOs on the gait of 14 healthy subjects and 29 
subjects with peripheral paresis of the dorsiflexors. For the healthy control subjects, AFO use 
resulted decreased dorsiflexion amplitude during LR, while the paretic subjects with AFOs 
demonstrated decreased dorsiflexion amplitude throughout the entire gait cycle [38]. Sustained 
activity of the dorsiflexor muscles may help to retain muscle mass over the long-term, and may 
be beneficial for patients with potential for musculoskeletal recovery. However, this dorsiflexion 
activity during stance may reflect an inefficient system for which energy expenditure might be 
reduced if the dorsiflexion activity decreased with AFO use. 
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The soft heel of the DRAFO was expected to permit ankle plantarflexion during LR, 
thereby necessitating dorsiflexor activity to prevent foot slap.  As such, dorsiflexion activity 
duration during stance with the DRAFO was expected to approximate the no AFO condition 
(Hypothesis 1). No significant differences in dorsiflexion activity duration during stance were 
observed between the DRAFO and no AFO conditions; Hypothesis 1 was therefore supported 
[with low power, likely attributed to the high variability in EMG activity (Appendix G)].  
As the soft heel of the DRAFO likely increases dorsiflexion activity during LR, 
dorsiflexion activity duration during stance was expected to differ from that with the 
conventional AFOs, particularly for the locked AFO that prohibits ankle plantarflexion during 
LR (Hypothesis 2). However, no differences in dorsiflexion activity duration during stance were 
observed between the DRAFO and conventional AFO conditions; therefore, Hypothesis 2 was 
not supported during stance phase, although the associated power was low (<0.01, Appendix G) 
due to high variability in EMG and small study population.  
 
5.2.2 Plantarflexion Activity 
 Plantarflexion activity for able-bodied subjects typically occurs during stance only, from 
TSt through PSw to provide powered push off to propel the limb into swing. This plantarflexion 
activity helps stabilize the ankle as the shank rotates over the forefoot (third rocker) [10]. With 
the potential exception of powered or leaf spring AFO designs, most AFOs do not provide active 
push off; these passive AFOs simply stabilize the ankle to assist shank rotation over the forefoot 
rocker.  As the plantarflexors are not expected to be active during swing, plantarflexion activity 
duration was investigated during stance only. 
100 
 
No differences in plantarflexion activity duration during stance were observed with 
DRAFO relative to the no AFO condition, nor with respect to the conventional AFOs. The 
DRAFO, with its plantarflexed alignment and external heel wedges, might be expected to affect 
plantarflexor activity during stance. However, no significant differences in plantarflexion activity 
duration were found, which may be attributed to: 1) high variability in plantarflexor activity 
duration, and 2) habitual plantarflexion activity during TSt-PSw for powered push-off, despite 
the orthotic plantarflexion constraint.  Geboers also noted sustained plantarflexion activity for 
both able-bodied and paretic subjects wearing AFOs during level treadmill walking [38]. 
 AFOs are not typically prescribed to address pathological plantarflexion activity, unless 
spastic plantarflexion activity is observed and it affects foot clearance during swing.  Excessive 
plantarflexion activity may be treated with an AFO with a plantarflexion stop (free, articulated 
AFO) or a rigid ankle joint (locked AFO or DRAFO), thereby preventing powered push-off 
during late swing and assisting foot clearance during swing.  
   
5.3 KINETICS 
 The COP quantifies the location of the GRF and may be used to investigate plantar 
loading patterns and load progression during the various sub-phases of stance. The COP can be 
used to assess balance and dynamic stability, contrasting the medial-lateral motion of the COP 
relative to the long-axis of the foot in the DRAFO and no AFO conditions, as well as for the 
DRAFO compared to the conventional AFOs. As the DRAFO has a soft heel, proprioception 
may be enhanced during IC and LR, resulting in COP progression that more closely mimics the 
no AFO condition, particularly during early stance.  
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 During LR, the COP progression of the DRAFO was more medial than for the no AFO 
condition with similar range of motion, as quantified by the peak medial/min lateral position 
(DRAFO: 3.63±15.76mm, no AFO: 14.78±12.51mm) and peak lateral position (DRAFO: 
21.91±10.08mm, no AFO 29.80±8.53mm). During MSt, the DRAFO COP progression was also 
more medial than for the no AFO condition (peak medial position: DRAFO = 21.08±13.63mm, 
no AFO = 30.30±9.57mm; peak lateral position: DRAFO = 36.99±13.92mm, no AFO = 
44.23±14.42mm). Similar differences were noted during both TSt (peak medial: DRAFO = 
29.79±21.50mm, no AFO = 42.88±15.18mm; lateral peak: DRAFO = 41.54±21.47mm, no AFO 
= 55.01±19.92mm) and PSw (peak medial only: DRAFO = 6.57±31.39mm, no AFO = 
33.16±17.77mm). 
During LR, the COP for the DRAFO was also significantly more medial than for the free 
AFO condition (peak lateral: DRAFO = 21.91±10.08mm, free AFO = 26.87±12.13mm). The 
COP with the DRAFO was also more medial than the free AFO condition during MSt (peak 
medial: DRAFO = 21.08±13.63mm, free AFO = 28.01±14.63mm). Similar observations were 
made during both TSt and PSw, for which the COP for the DRAFO was again more medial than 
that for the no AFO and Free AFO condition: TSt (peak lateral: DRAFO = 41.54±21.47mm, free 
AFO = 50.94±23.12mm) and PSw (peak medial (DRAFO = 6.57±31.39mm, free AFO = 
28.12±27.21mm). 
  
5.3.1 COP Progression 
 During level, treadmill walking for able-bodied subjects, the COP is initially located at 
the center of the heel during IC, progressing forward toward the toes at TO [47]. The progression 
of COP moves laterally with respect to the long-axis of the foot from the heel, from IC through 
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MSt, before moving towards the long axis of the foot, with a location medial to this axis during 
PSw [Figure 2.15]. In the current study, however, the COP progression for the DRAFO condition 
relative to that observed for the no AFO condition was consistently more medial to the long axis 
of the foot. 
 The COP relative to the long axis of the foot was more medial for the DRAFO (and free 
AFO condition) relative to the no AFO condition, from LR through PSw. The more medial COP 
progression may be attributed to wearing a rigid AFO device, and although increased stability 
would indicate that step width would be decreased, no significant differences were found in step 
width between conditions. It is also possible that the wedges may have induced a more 
pronated/inverted foot than in the conventional AFO conditions, although the wedges were only 
intended to affect sagittal plane stability. More lateral COP progressions have been postulated to 
increase stability or dynamic balance; both Balmaseda (able-bodied subjects wearing AFOs) [48] 
and Wang (hemiparetic subjects wearing rigid AFOs) [20] observed more lateral COP 
progression with AFOs relative to the no AFO condition.  In contrast to the current study, these 
studies reflected impaired balance with AFO use, necessitating the wider base of support and 
more lateral COP progression trajectory. 
The soft heel of the DRAFO was expected to increase proprioception during IC and LR, 
resulting in COP progression during IC through LR that more closely approximates the no AFO 
condition (Hypothesis 1); these effects were not expected in the latter sub-phases of stance (e.g. 
MSt-PSw). However, COP progression differed between the DRAFO and no AFO conditions 
during LR; Hypothesis 1 was not supported with modest to high power (0.32-0.92, Appendix G). 
 The soft heel and posterior heel wedge of the DRAFO were expected to differentiate 
COP progression for the DRAFO relative to the conventional AFOs during IC through LR 
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(Hypothesis 2). The COP progression with the DRAFO differed from the locked AFO during 
LR; differences in COP progression were also observed during a portion of LR with the free 
AFO condition.  As such, Hypothesis 2 was largely supported with medium power (>0.5, 
Appendix G).  
 
5.4 STUDY LIMITATIONS 
 This study made several assumptions that influenced study design, testing, data 
processing, and data analysis. For example, research subjects were restricted to young able 
bodied subjects.  The use of this homogeneous population permitted analysis of AFO effects, 
free from potential variability due to neuromusculoskeletal impairment, pathologies and aging. 
This subject population likely exhibited less variability, thereby increasing the power associated 
with the study parameters (e.g., knee, ankle, shank, and thigh kinematics, dorsi-/plantar-flexion 
muscle activity duration, and COP progression). As such, these results may not directly translate 
to patient populations with specific neural, muscular and/or skeletal pathologies.  These patient 
populations would likely exhibit greater heterogeneity and parameter variance, requiring greater 
population sizes for sufficient power.   
 Another factor regarding the experimental design that may have influenced the observed 
results was that subjects wore the same shoes for all conditions; larger shoes were not donned to 
accommodate AFO bulk. While the shoe constraint minimized potential variability due to 
differences in heel height and sole/upper compliance, the tight fit in the AFO conditions may 
have reduced ankle mobility and introduced discomfort. Footwear and footwear fit have been 
shown to impact COP [49]. Despite the potential impact of footwear and shoe fit on COP 
progression, consistent footwear was thought to be a more important study design consideration. 
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A final experimental factor that may have affected the results was that ambulation trials 
were restricted to level treadmill walking, rather that overground or non-level terrain gait.   
Studies have shown that level treadmill versus overground ambulation may result in several 
changes; treadmill walking has been observed to reduce dorsiflexion, decrease internal knee 
extensor moment during early and late stance, increase hip extensor moment (early stance and 
swing), decrease dorsiflexion activity during stance, and increase braking and vertical GRFs 
[50]. Lower extremity joint and segment kinematics, however, are largely the same for level 
treadmill vs overground walking, and therefore the joint and segment kinematic findings were 
likely not affected by the treadmill ambulation. The advantage of treadmill ambulation is that the 
subject’s velocity is controlled, although their cadence and step length may vary.  As study 
parameters were contrasted between AFO conditions and all trials were conducted at 
approximately the same walking velocity on a level treadmill, observed differences between 
AFO conditions might extend to overground walking at similar walking speeds.  
 Motion capture was based on reflective markers placed on the skin and AFO to track 
segments and joint motion. While skin motion likely introduced minimal error to the joint and 
segment kinematics (e.g. less than 4.4° [51]), marker placement on the AFO to approximate 
ankle position may not accurately approximate the joint, and does not mimic the motion of the 
actual ankle. As knee and ankle motion, as well as SVA and TVA motion were based on at least 
one marker positioned on the skin, kinematic errors likely did not affect key findings. The lateral 
offset of the malleoli markers on the right AFO-limb were addressed during kinematic data 
processing, as anthropometric measures at the malleoli were taken both with and without the 
AFO. 
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One factor that likely influenced data analysis was the use of a single MVC trial to scale 
the EMG activity. With only one MVC trial, estimates of peak EMG amplitudes may have been 
in error.  As such, the MVC might not assess the true MVC, and errors may have been 
introduced in both scaling and activity duration calculations. 
Another potential data analysis error involved the calculation of the TVA and SVA. 
These segment angles were based on sagittal plane location of only two markers per segment. 
Therefore, errors in sagittal plane motion of these markers, due to skin motion or other factors, 
may influence the accuracy of these calculations. Calculation of SVA and TVA using an 
additional marker or marker triad might improve the accuracy of these measures and the 
associated SVA and TVA cross-over times. 
 
5.5 FUTURE STUDY 
 Based on this study, further testing is recommended to fully contrast ambulation in the 
DRAFO and traditional AFOs. Future research might investigate the impact (e.g., stability, 
SSWS, SLS duration, shank inclination velocity) of increased knee flexion in the DRAFO for 
subjects with cerebral palsy, hemiplegia with knee osteoarthritic, and genu recurvatum. Such 
studies should include a subject population of at least 12 subjects, based on power analyses 
conducted with the current data. In addition to kinematic (inclusive of step width, FPA, and other 
coronal and transverse plane parameters), EMG, and kinetic measures, clinical measures such as 
the TUG, BBS  and comfort questionnaire should be included to gain further insight into the 
effects of the DRAFO’s soft heel, plantarflexed alignment, and external heel wedges.  
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 As the functional outcomes of the DRAFO are likely influenced by its effective 
alignment, future work might also investigate posterior heel wedges of various heights to help 
develop prescription and fitting guidelines for the DRAFO. 
 
5.6 SUMMARY  
The design features of the DRAFO, namely the soft heel, plantarflexed alignment, 
external heel wedges, and solid ankle, resulted in several kinematic differences between the 
DRAFO and no AFO conditions during stance.  These kinematic differences included: increased 
knee flexion and plantarflexion, as well as delayed thigh cross-over time, with the DRAFO. The 
DRAFO also resulted in reduced dorsiflexion EMG activity during swing phase – as did the 
conventional AFOs. Finally the DRAFO moved the lateral COP progression more medially 
when compared to the no AFO condition.  These design features of the DRAFO were expected 
to result in several gait parameters (e.g., ankle plantarflexion during early stance, cross-over 
times of the shank and thigh vertical angles during stance, step width and COP progression 
during LR) that would more closely approximate the no AFO condition, as posed by Hypothesis 
1.  Hypothesis 1, however, was only supported for a subset of these gait parameters, namely 
ankle kinematics during LR, step width, and dorsiflexion activity duration during stance.  
The DRAFO’s altered alignment and addition of the heel wedge were also expected to 
result in differences from conventional AFOs for specific gait metrics (e.g., ankle and knee 
kinematics, cross-over times of the shank and thigh vertical angles during stance, peak FPA, step 
width, stance phase dorsiflexion activity duration, and mediolateral motion of the center of 
pressure), as postulated by Hypothesis 2. Hypothesis 2 was also supported for a subset of gait 
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parameters, specifically knee kinematics during stance, ankle kinematics from LR through MSt 
as well as during swing, and TVA cross-over time during stance.   
The observed increased knee flexion during stance with the DRAFO may enhance shock 
absorption during LR and minimize potential knee joint pain during weight acceptance, possibly 
benefiting those who suffer from knee OA; the increased knee flexion during stance may also 
benefit patients with genu recurvatum. The DRAFO’s soft heel and more plantarflexed ankle 
may also assist weight acceptance and the first rocker, assisting foot flat.  However, the delayed 
TVA cross-over time with the DRAFO may be attributed to the increased knee flexion during 
stance, and may result in prolonged stance. Finally, more medial COP progression with the 
DRAFO and conventional AFOs may reflect increased stability or dynamic balance in these 
AFOs, although no differences in step width were observed between any AFO conditions.  
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Chapter 6: CONCLUSION 
 AFOs are commonly prescribed to compensate for spasticity/weakened muscles in the 
plantar/dorsiflexors, provide stability during stance and assist with foot clearance during swing. 
Rigid AFOs maximize stability during stance and provide assistance with clearance during 
swing, fully restricting the mobility of the ankle and subtalar joints. The sole function of 
articulating AFOs is to provide frontal plane stability during stance.   
 The DRAFO is a rigid AFO that includes a soft inner shell and a rigid polypropylene 
outer shell with heel cutout. As both rigid AFOs and articulating AFOs with a plantarflexion stop 
provide support for the plantar surface, ankle and subtalar joints, proprioception during stance is 
reduced. The inclusion of the heel cutout and soft liner of the DRAFO may increase 
proprioception during LR. Additional design features of the DRAFO include a plantarflexed 
alignment with supplemental external heel wedges to incline the shank during MSt; together 
these features may accelerate forward progression of the body COM during stance relative to 
conventional AFOs. 
 The purpose of this study was to contrast the DRAFO relative to the no AFO condition, 
and relative to conventional AFOs during level treadmill ambulation. The specific variables 
analyzed in this study included: kinematic measures (ankle and knee joint angles in the sagittal 
plane, SVA and TVA cross-over time, step width, and FPA), muscle activity duration 
(dorsiflexors and plantarflexors), and COP progression. The specific research hypotheses 
investigated in this study were:  
1) Gait parameters (e.g ankle plantarflexion during LR, swing phase SVA and TVA cross-
over times, dorsiflexion activity duration during stance, step width, and COP progression during 
LR) with the DRAFO will approximate that of the no AFO condition.  
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2) Gait parameters (e.g. ankle and knee kinematics, stance phase SVA and TVA cross-over 
times, foot progression angle, step width, stance phase dorsiflexion activity duration, and COP 
progression during LR) with the DRAFO will differ from that for articulating and rigid AFOs.  
The design features of the DRAFO, namely the soft heel, plantarflexed alignment, 
external heel wedges, and solid ankle, resulted in several kinematic differences between the 
DRAFO and no AFO conditions during stance.  These kinematic differences included: increased 
knee flexion and ankle plantarflexion, as well as delayed thigh cross-over time, with the 
DRAFO. The DRAFO also resulted in reduced dorsiflexion EMG activity during swing phase – 
as did the conventional AFOs. Finally the DRAFO had a more medial peak COP progression 
when compared to the no AFO condition, although the COP progression for all conditions was 
lateral to the long axis of the foot.  These design features of the DRAFO were expected to result 
in several gait parameters (e.g., ankle plantarflexion during early stance, cross-over times of the 
shank and thigh vertical angles during stance, step width and COP progression during LR) that 
would more closely approximate the no AFO condition, as posed by Hypothesis 1.  Hypothesis 
1, however, was only supported for a subset of these gait parameters, namely ankle kinematics 
during LR, step width, and dorsiflexion activity duration during stance. 
The DRAFO’s altered alignment and addition of the heel wedge were also expected to 
result in differences from conventional AFOs for specific gait metrics (e.g., ankle and knee 
kinematics, cross-over times of the shank and thigh vertical angles during stance, peak foot 
progression angle, step width, stance phase dorsiflexion activity duration, and mediolateral 
motion of the center of pressure), as postulated by Hypothesis 2. Hypothesis 2 was also 
supported for a subset of gait parameters, specifically knee kinematics during stance, ankle 
110 
 
kinematics from LR through MSt as well as during swing, and TVA cross-over time during 
stance. 
Joint and segment kinematics provide insight into how individuals walk; gait pathologies 
due to musculoskeletal impairment and/or orthotic intervention often induce compensatory 
mechanisms. In this investigation of young, able-bodied subjects during treadmill ambulation at 
self-selected walking speeds, the DRAFO resulted in increased knee flexion during early/MSt 
and swing, with increased extension during late stance. Greater stance flexion during LR may 
reduce joint loading, while potentially increasing knee extensor activity to counter the 
corresponding internal knee flexion moment. As expected, the plantarflexed alignment the 
DRAFO resulted in greater ankle plantarflexion throughout gait, relative to conventional AFO 
conditions. This increased plantarflexion, together with the external heel wedges and soft heel, 
however, more closely approximated the no AFO condition, providing a more natural initiation 
of the gait cycle.  Increased plantarflexion may also be beneficial during PSw, assist the 3rd 
rocker in preparation for swing. During swing, however, increased plantarflexion likely hinders 
foot clearance and may result in compensatory kinematics, although increased knee flexion was 
not observed. As the design features of the DRAFO were in the sagittal plane, no frontal or 
coronal plane effects were expected. However, the DRAFO altered the minimum FPA compared 
to the no AFO condition. This alteration may affect knee kinematics and kinetics in the frontal 
and transverse planes. 
EMG activity can provide insight into musculature use and can help to better understand 
the effects of the DRAFO on dorsi/plantarflexion activity duration. Increased activity duration 
might be indicative of increased energy expenditure and potential risk of muscle fatigue.  The 
soft heel of the DRAFO was expected to approximate dorsiflexion activity duration of the no 
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AFO condition, with the ankle dorsiflexors acting to prevent foot slap during LR. The rigid 
frame of the DRAFO, like that of the conventional AFOs, was expected to minimize dorsiflexion 
activity during swing. Contrary to expectations, dorsiflexion activity in the DRAFO did not 
approximate the no AFO condition.  In addition, none of the AFOs reduced dorsiflexion activity 
during swing; this anomaly is likely attributed to habit and muscle memory as all subjects were 
healthy. Muscle activity duration with the DRAFO therefore does not reflect any functional 
advantage relative to conventional AFOs, although this finding should be further investigated 
with a clinical population. 
The progression of the COP, together with step width and FPA, were investigated as 
potential measures of stability during gait. The soft heel of the DRAFO was expected to improve 
proprioception during LR, resulting in COP progression that approximated the no AFO 
condition, thereby differing from that of conventional AFOs. However, the COP progression 
during LR remained similar to that of the conventional AFOs. The potential advantages of the 
soft heel are therefore unknown, or may have been masked by the plantarflexion alignment.  
To further investigate the potential effects of the DRAFO on stability, both step width 
and FPA were measured. Significant differences were found between the DRAFO and no AFO 
conditions, but these changes were likely not clinically significant. However, further research 
into FPA and its effects on the knee moment are warranted. No significant differences in step 
width were found between AFO conditions, the effects of stability on the DRAFO are uncertain. 
There are several study limitations that must be taken into consideration. The subject 
population was small (10 subjects) and consisted solely of young, able-bodied subjects, thereby 
affecting analysis of muscle activity duration. Finally, ambulation trials were performed on a 
level treadmill, providing constant velocity analysis within the trials, but which may differ from 
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overground walking and ambulation over non-level terrain. Additionally, the self-selected 
velocity of some subjects varied between conditions which may have affected the analysis of 
TVA, SVA and muscle activity duration as a percent of the gait cycle.  
Despite these limitations, the study provides insight into the effects of various DRAFO 
design features (soft heel, plantarflexed alignment, external heel wedges, and rigid frame) on gait 
compared to both the no AFO and conventional AFO conditions. Of the measures investigated, 
only ankle and knee joint kinematics differed between the DRAFO and conventional AFOs. The 
increased ankle plantarflexion with the DRAFO better approximated normal kinematics during 
LR, and may provide a more effective lever arm for the 3rd rocker in preparation for swing. The 
DRAFO also increased knee flexion during early and late stance, as well as during swing. This 
may reduce lower limb loading during early stance, but may increase energy expenditure due to 
increased quadriceps effort during early stance to counter the internal knee flexion moment and 
increased hip and/or knee flexor activity during swing to assist toe clearance. These results 
support DRAFO use for individuals with lower limb joint pain and perhaps mild genu 
recurvatum. 
Future analysis of the DRAFO might address optimization of alignment and external heel 
wedge height, muscle activity of the quadriceps and hamstrings, COP progression, COP 
progression velocity, and energy consumption to further investigate the impact of the DRAFO 
design features on ambulation. The subject population might be extended to include clinical 
populations that are candidates for AFO treatment intervention.  
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Appendix A: Statistical analysis of peak knee flexion angle and TVA cross-over times. 
 
 
 
IC 
Early 
stance 
Late 
stance 
Swing 
Normality 0.38 0.815 0.927 0.565 
GLM 0.003 <0.001 <0.001 0.03 
Friedman's Test XXXX XXXX XXXX XXXX 
no AFO - 
DRAFO 
<0.05 <0.05 <0.05 >0.05 
no AFO – free >0.05 >0.05 >0.05 <0.05 
no AFO - locked >0.05 >0.05 <0.05 >0.05 
DRAFO - free <0.05 <0.05 <0.05 >0.05 
DRAFO - locked <0.05 <0.05 <0.05 >0.05 
 
 
 
 
TVA 
Stance 
TVA 
Swing 
TVA 
Stance 
(sec) 
TVA 
Swing 
(sec) 
Normality 0.683 0.297 0.738 0.011 
GLM <0.001 <0.001 <0.001 XXXX 
Friedman's Test XXXX XXXX XXXX 0.008 
No AFO - 
DRAFO 
<0.05 <0.05 <0.05 0.019 
No AFO - free <0.05 <0.05 >0.05 0.541 
No AFO - locked <0.05 >0.05 >0.05 0.919 
DRAFO - free <0.05 <0.05 <0.05 0.006 
DRAFO - locked <0.05 <0.05 <0.05 0.032 
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Appendix B: Statistical analysis for peak sagittal plane ankle angle and SVA cross-over 
times. 
 
 
 
 
 Stance 
plantar 
Stance 
dorsi 
Late 
plantar 
Swing 
dorsi 
Normality 0.467 0.799 0.724 0.007 
GLM <0.001 <0.001 <0.001 XXXX 
Friedman's Test XXXX XXXX XXXX 0.008 
no AFO - 
DRAFO 
>0.05 <0.05 <0.05 <0.05 
no AFO - free <0.05 <0.05 <0.05 >0.05 
no AFO - locked <0.05 >0.05 <0.05 >0.05 
DRAFO - free <0.05 <0.05 >0.05 <0.05 
DRAFO - locked <0.05 <0.05 >0.05 <0.05 
 
 
SVA 
Stance 
SVA 
Swing 
SVA 
Stance 
(sec) 
SVA 
Swing 
(sec) 
Normality 0.675 0.315 0.986 0.014 
GLM 0.17 0.009 0.037 XXXX 
Friedman's Test XXXX XXXX XXXX 0.017 
no AFO - 
DRAFO 
XXXX <0.05 >0.05 0.032 
no AFO - free XXXX >0.05 >0.05 0.61 
no AFO - locked XXXX >0.05 >0.05 0.476 
DRAFO - free XXXX <0.05 >0.05 0.006 
DRAFO - locked XXXX >0.05 >0.05 0.019 
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Appendix C: Statistical analysis for foot progression angle 
 
 
 Min FPA Max FPA 
Normality 0.005 0.481 
GLM XXXXX 0.454 
Friedman's Test 0.045 XXXXX 
no AFO - DRAFO <0.05 XXXXX 
no AFO - free >0.05 XXXXX 
no AFO - locked >0.05 XXXXX 
DRAFO - free >0.05 XXXXX 
DRAFO - locked >0.05 XXXXX 
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Appendix D: Statistical analysis of step width 
 
 
 Step width 
Normality 0.775 
GLM 0.092 
Friedman's Test XXXX 
no AFO - DRAFO XXXX 
no AFO - free XXXX 
no AFO - locked XXXX 
DRAFO - free XXXX 
DRAFO - locked XXXX 
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Appendix E: Full statistical information for EMG (dorsi/plantar) activity duration 
 
 
 Dorsi 
Stance 
Dorsi 
Swing 
Plantar 
Stance 
Normality 0.193 0.086 0.372 
GLM 0.220 <0.001 0.077 
Friedman's Test XXXXX XXXXX XXXXX 
no AFO - 
DRAFO 
XXXXX <0.05 XXXXX 
no AFO - free XXXXX <0.05 XXXXX 
no AFO - locked XXXXX <0.05 XXXXX 
DRAFO - free XXXXX >0.05 XXXXX 
DRAFO - locked XXXXX >0.05 XXXXX 
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Appendix F: Full statistical information for COP progression 
 
 
 LR 
Min 
LR 
Max 
MST 
Min 
MST 
Max 
TST 
Min 
TST 
Max 
PSw 
Min 
PSw 
Max 
Normality 0.398 0.324 0.334 0.312 0.472 0.567 0.948 0.241 
GLM <0.001 0.001 0.001 0.036 0.004 0.003 0.003 0.143 
Friedman's Test XXXX XXXX XXXX XXXX XXXX XXXX XXXX XXXX 
no AFO - 
DRAFO 
<0.05 <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 XXXX 
no AFO - free <0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 XXXX 
no AFO - 
locked 
<0.05 <0.05 >0.05 >0.05 >0.05 >0.05 >0.05 XXXX 
DRAFO - free >0.05 <0.05 <0.05 >0.05 >0.05 <0.05 <0.05 XXXX 
DRAFO - 
locked 
>0.05 >0.05 >0.05 >0.05 >0.05 <0.05 >0.05 XXXX 
 
Normality testing, statistical significance testing (GLM/Friedman’s), and post-hoc power testing 
for knee COP progression throughout stance phase (LR-PSw) 
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Appendix G: Full power/effect size information for all variables 
 
 
Measure Specific Phase Effect size Power 
Knee Angle    
 IC 0.91 0.72 
 LR 0.92 0.74 
 MSt 1.02 0.82 
 Sw 0.0065 0.05 
Ankle Angle    
 Stance plantar 0.013 0.05 
 Stance dorsi 1.44 0.98 
 Swing plantar 2.56 0.99 
 Swing dorsi 0.74 0.55 
TVA Crossing    
 Stance 0.41 0.21 
 Swing 0.66 0.46 
SVA Crossing    
 Stance 0.99 0.79 
 Swing 0.35 0.17 
Dorsi Activity    
 Stance 0.0067 0.05 
 Swing 1.02 0.91 
Plantar 
Activity 
   
 Stance 0.28 0.13 
Medial COP    
 LR 0.78 0.59 
 MSt 0.74 0.55 
 TSt 0.64 0.44 
 PSw 1.19 0.92 
Lateral COP    
 LR 0.79 0.61 
 MSt 0.52 0.32 
 TSt 0.65 0.45 
 PSw 0.96 0.77 
FPA    
 Min 0.47 0.39 
 Max 0.26 0.19 
Step width    
 Mean 0.39 0.30 
 
